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Lipids such as diacylglycerol (DAG) and phosphatidic acid (PA) have been 
shown to play key roles in cell signaling events. The anchoring of proteins to the 
membrane via DAG or PA binding helps regulate protein function and localization and is 
also involved in normal and disease-related cellular processes. In order to fully 
understand these pathways, it is necessary to develop synthetic analogues that mimic 
the natural species, but that also have a means which allows investigation of the 
process at the molecular level. This dissertation will detail the design and synthesis of 
novel lipid-based probes possessing a reactive azide tag, which can then be 
functionalized via the 1,3-dipolar cycloaddition reaction (“click” chemistry) to produce a 
series of analogues with fluorescence and photo-cross-linking capabilities. Initial 
receptor-ligand binding results will be presented, along with the description of future 
studies that will provide insight into the mechanism of such interactions. 
In addition, the immobilization of whole liposomes onto a surface will be 
discussed.  Techniques such as measuring the fluorescence-after-immobilization and 
dye leakage assays were developed and optimized to prove that immobilization onto a 




high-throughput, micro-plate assay to detect the binding of a protein to a membrane. 
Here, liposomes which express a specific ligand at the surface will be immobilized and 
introduced to various receptors. Appropriate techniques will be employed to determine 
whether a given receptor binds to the expressed ligand. 
Lastly, an initial attempt at the development of an artificial vesicle fusion system 
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Lipids are biological molecules that consist of a polar headgroup, typically a 
phosphoester, and hydrophobic acyl tails. The lipids align themselves to form a bilayer 
structure which constitutes the bulk of cellular membranes. Although membrane 
surfaces may be decorated with a litany of biological molecules, and integral membrane 
proteins may be embedded within the bilayer, the main components of the membrane 
are lipids. These lipids are divided into two main classes. Bulk lipids including 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylglycerol 
(PG) account for the majority of the lipid composition, and signaling lipids such as 
diacylglycerol (DAG), phosphatidic acid (PA), and the phosphoinositides (PIPns) 
account for minor percentages of the lipid composition. It is now known that DAG,1-5 
PA,5-7 and PIPns
8-14 are linked to a litany of crucial cellular events. One particular 
function involves the docking of peripheral proteins onto membrane surfaces through 
targeted interactions with a specific signaling lipid(s). These interactions generally 
regulate the location of proteins within the cell and also regulate their function (figure 
1.1).2, 3, 15, 16 Biological function of the receptor can be directly regulated through such 
binding interactions or indirectly regulated, as often times binding of the receptor to 
another membrane bound protein occurs.2, 3, 15, 17 These binding interactions also 





Figure 1.1. Representation of the recruitment of peripheral proteins to the 




signaling lipids within the cell are closely regulated, lipid-specific receptors can be 
recruited to specific cellular locations based upon where the lipid is presented.18 Upon 
binding to the lipid a signal is sent to the protein. In certain cases, detachment of the 
protein followed by relocation to a different cellular location allows transfer of that signal 
to various pathways. Because many of these interactions have been linked to various 
diseases, it is important to elucidate the exact details of the protein-lipid binding events.  
While specific examples will be discussed in detail in relevant chapters, it suffices 
to say that the actual processes are much more nuanced than depicted in figure 1.1. 
Many complex factors are involved and must be characterized in order to decipher the 
binding mechanism. Such is the case with the protein kinase C (PKC) family. The 
inability to completely characterize the binding specificity and cellular localization of 
each isozyme, of which at least eleven are known, has hindered the elucidation of the 
specific function of each.19  
One aspect that can complicate determining the binding specifics is the 
possibility for the receptor to bind to the membrane in a multivalent fashion.20, 21 In such 
a case, one must consider that each of the domains may possess identical or varying 
affinities for the ligand. It is known that within the PKC family, which bind DAG with two 
tandem domains, the affinity for DAG and molecules that compete for the DAG binding 
sites vary from isozyme to isozyme as well as between the two domains.2 Another 
related factor involves the actual specificity for the lipid by a domain. An example of this 
presents itself in the study of the PIPns. It is well documented that the PIPns are 




FYVE, PX, PROPPIN,22 ENTH, ANTH, FERM, and Tubby domains.9, 10, 14 
Characterization of binding events between PIPns and receptors containing these 
domains is complicated by varying affinities for each domain, low sequence homologies 
among some of the domains, and the number of PIPn isomers, each of which will have 
different specificities for binding to each type of domain.   
Another aspect that deserves consideration when probing binding events is the 
manner in which the protein interacts with the membrane. The cellular membrane is 
divided into three sections (figure 1.2).2, 23 Initially, the recruitment of the protein to the 
polar membrane surface is driven primarily by electrostatic interactions, as all 
membranes contain some amount of anionic phospholipids and most peripheral 
proteins contain some positive amino acid residues.2 Other interactions that occur at the 
polar surface, such as ion-ion and ion-dipole attractions, between signaling lipid and 
receptor may also be responsible for membrane recruitment,23 but studies have shown 
that these initial nonspecific electrostatic interactions are required.2, 24 Proteins that 
specifically interact at the polar surface are termed headgroup-driven (S-type)2 and will 
generally recognize probes primarily via the headgroup.10 Following this initial 
anchoring, other types of interactions may occur, which greatly enhance binding energy 
leading to full anchoring onto the membrane that in turn regulates activity.2 For 
example, proteins that possess hydrophobic and aromatic residues around the binding 
domain may penetrate into the other regions of the bilayer. Depending upon the depth 
of the penetration, these proteins are termed I-type (interfacial region) or H-type 





Figure 1.2. The membrane bilayer is divided into three different sections, each 





and ionic-hydrogen bonds, while those occurring in the hydrophobic core consist of van 
der Waals interactions and non-ionic hydrogen bonding.23 The study of proteins that 
bind to the membrane via these interactions would require the membrane environment 
and full lipid analogues when probing the binding event.  
Lipid probes have proven to be very useful in scrutinizing these binding events.14, 
25-33 A probe is an analogue of a natural lipid that is tagged with a reporter moiety 
capable of providing details related to a specific event.34 When designing the probe, 
there are several factors that should be considered. First, the lipid probe must be 
designed in a manner such that it mimics the natural lipid, and the receptor still 
recognizes it as a ligand. Second, the synthesis should produce the target probes from 
simple, economically feasible, commercially available, and enantiopure starting 
materials. While specific examples for manipulation of the headgroup and acyl tails via 
enzymatic means have been used in the synthesis of lipids and probes,30, 35-37 they are 
often expensive, require small scale reaction conditions, limit the variations in the types 
of probes that can be obtained, and often give rise to a mixture of products instead of a 
single species. Also, one must determine the most beneficial location for the placement 
of the reporter molecule, which will allow investigation of the interaction at the molecular 
level by providing a means for the direct detection of binding. Attaching it directly to the 
headgroup could greatly interfere with binding. If it is incorporated into the tail, it must be 
non-polar such that it remains embedded within the hydrophobic membrane core. The 
other potential location for a modification to be made is in place of a hydrogen at the sn-




functional groups required to readily place a synthetic handle at this location.32 
However, this site could be a very appealing location for modifying the lipid structure as 
it places the reporter molecule in proximity of the headgroup to allow for a more 
sensitive detection of binding, yet as far away as possible from the phosphodiester 
binding motif.  
One of the main goals in lipid probe design is to produce analogues via a 
process that is as efficient as possible. Many synthetic procedures for lipid probes 
require the full synthesis to be carried out for each probe.14, 25, 26, 28-33 Therefore, a 
modular approach is beneficial as it allows for the synthetic generation of a common 
lipid precursor followed by the ability to efficiently modify this scaffold in order to obtain 
an arsenal of probes of use for different studies. The key to developing a modular 
approach is the incorporation of a synthetic handle that is stable under most conditions, 
yet reacts efficiently via a specific reaction. The azide functionality has become a 
popular choice as a synthetic handle due its ability to meet these requirements.  
Azides are relatively small, so they pose no steric limitations for remaining 
synthetic steps. They are fairly stable under acidic and basic conditions, and at 
moderate temperatures, yet they efficiently react through the copper-catalyzed 1,3-
dipolar cycloaddition (“click” chemistry),38-40 as shown in  figure 1.3.   “Click” chemistry 
has become increasingly popular since its discovery for several reasons. First, it is 
carried out under very mild conditions. Second, the reaction is specific for the azide and 
alkyne, thereby increasing the efficiency of the reaction and decreasing the amount of 





Figure 1.3. Various chemical reactions for the modification of azides that can be 










not react with species found within the cell, which maintains the high selectivity of the 
reaction when carried out in vivo. 
Azides can also be efficiently modified via the Staudinger ligation,41-43 which is 
also a bio-orthogonal reaction (figure 1.3). The conditions are not as mild as those for 
the “click” reaction, so certain functionalities may not be as tolerant of this modification 
strategy. Azides can also be used as a masking group for amines, generating the amine 
upon reduction (figure 1.3).44 Using these approaches, a variety of reporter molecules 
can be incorporated onto the lipid structure at various locations through single step 
manipulation of the azide synthetic handle. 
The use of a fluorescent tag as the reporter molecule is a popular strategy 
among previously reported lipid probes.34 For example, Schultz and coworkers have 
developed a probe containing alkyne functionalities in the lipid tails.45 The lipid was 
incorporated into living cells and, following the attachment of a fluorophore via “click” 
chemistry, distribution of the probe within cellular membranes was monitored. 
The use of fluorescence to monitor binding events can be taken one step further. 
Förster resonance energy transfer (FRET) is a radiationless energy transfer from an 
excited donor molecule to an acceptor molecule through long-range (10–100 Å) dipole-
dipole couplings.46-48  Thus, FRET is a useful technique for detecting changes in 
proximity between the donor and acceptor, as it is highly dependent upon the distance 
between them. The closer the donor is to the acceptor, the more FRET is observed and 
vice versa. The effectiveness of this approach is evidenced through the work of 




monitor the multivalent binding of cholera toxin to gangliosode GM1. 
Another approach to investigating protein-lipid binding is photoaffinity labeling.51 
In this application, tags are incorporated that generate highly reactive species, such as 
radicals or carbenes, upon exposure to light. These reactive intermediates then form a 
covalent bond to the lipid-bound receptor. Prestwich and co-workers have developed a 
series of photoaffinity probes, designed around the phosphoinositides, capable of 
interacting with various PIP receptors.14, 26, 31, 33  Photoaffinity labeling can also be 
extended to protein profiling, a method in which a series of proteins that target a specific 
lipid are fished out of a complex mixture of proteins.27 Here, cross-linking is coupled with 
a secondary tag that allows purification or detection of the receptor-ligand complex. 
Ultimately, both processes can be used for the identification of new receptors and in 
mapping the sequence of the binding domain.  
One final tag that is of great importance in lipid probes is biotin. Due to its tight 
binding to the protein streptavidin (Kd ≈ 10
-15 M),52 biotin can be used to purify 
conjugates away from species not tagged with the biotin, as in protein profiling. The 
incorporation of biotin onto lipids has also proven useful for the immobilization of 
liposomes onto an avidin coated surface.52-56 
 The work presented within this dissertation is focused around two common 
themes. First, the design, synthesis, and evaluation of signaling lipid probes will be 
explored. Each family of probe will be accessed from a common scaffold bearing an 
azide. “Click” chemistry will then be used to functionalize the probes with a litany of 




effective our probes serve as a mimic of the natural lipid. Analogues that exhibit 
comparable binding constants as the natural ligand will be used in further investigation 
of the binding event. Second, unnatural lipids accessed from a modular azido-scaffold 
will be synthesized and used in the development of techniques such as microplate 





















Chapter 2: Synthesis, Functionalization, and Biological Evaluations of 
Azide–Labeled Diacylglycerol (DAG) Analogues for the Modular 
Access to Lipid Probes 
 
 
Background and Significance 
Diacylglycerol (DAG) is a glycerolipid that contains two fatty acid tails at the sn-1 
and sn-2 positions and a primary hydroxyl group at the sn-3 as shown in figure 2.1. 
Most of the DAG present in the cell arises from lysophosphatidic acid (LPA) (figure 
2.1).1 Following acylation of LPA to furnish phosphatidic acid (PA), PA 
phosphohydrolases (PAPs) transform PA into DAG. The enzymes phospholipase C 
(PLC) and phospholipase D (PLD) are both involved in DAG production via hydrolysis of 
phospholipids, although these are not mainstream routes for the generation of DAG 
(figure 2.1). Despite its simplistic structure, DAG has been linked to various diseases 
such as diabetes57 and cancer.19, 58 In order to learn exactly how DAG is involved in the 
generation or promotion of such diseases, the details that govern the binding of 
receptors to DAG need to be understood.  
A well studied class of DAG receptors is the protein kinase C (PKC) family of 
proteins. PKC enzymes bind to DAG producing a direct relationship between binding 
and action.59  There are at least eleven different isozymes of PKC and three classes of 
PKC enzyme, each of which bind DAG in a unique fashion. Conventional PKC enzymes 





Figure 2.1. Biosynthesis of DAG adapted from ref 1. Major pathways are 
indicated with red reaction arrows. Minor pathways that produce DAG that is not 














dependent upon the presence of DAG and anionic phospholipid, but require no calcium 
for binding. Atypical PKC enzymes are DAG, calcium and phospholipid independent.1-4, 
59 In order to bind DAG, PKC enzymes require two cysteine-rich, highly conserved (C1) 
domains. Conventional and novel PKC enzymes bind DAG using two C1 domains, 
denoted C1A and C1B. In addition to the tandem C1 domains, conventional and novel 
PKC enzymes contain a conserved 2 (C2) domain. C2 domains recognize anionic 
phospholipids on the membrane surface, to which they are attracted to through 
electrostatic interactions.2 In order for C2 domains of conventional PKC enzymes to 
bind the anionic phospholipid, calcium must be present. The C2 domains of novel PKC 
enzymes bind to the anionic phospholipid without calcium. Atypical isozymes only 
contain a single C1 domain and therefore do not bind DAG or its analogues.59 
PKCs have long been known to play a role in tumorigenesis.19, 58, 60 Deciphering 
this role is a daunting task due to the number of isozymes, each of which play various, 
and often opposing, roles in cellular pathways. A current hypothesis is that subtle 
differences in binding patterns between isozymes promote their different and distinct 
cellular locations.3, 16 In turn, these variations in cellular location govern their 
involvement in specific pathways. The binding mechanism is further complicated by the 
multivalent interactions discussed above, which allow variations in affinity and specificity 
to occur between isozymes. For example, PKCε and PKC  both contain C1 domains 
that bind DAG with high affinity at each domain.2 PKCα and PKCδ, on the other hand, 
tightly bind DAG with only their C1A domain.61 Anionic lipid specificities also arise as 




nature of these events requires DAG-based probes that will provide the ability to 
investigate association at the molecular level so as to actually detect and monitor the 
binding event.  
 
 
Synthetic Procedures for DAG Analogues 
Although synthetic lipid probes have been utilized to scrutinize protein–lipid 
binding events,14, 25-33 these investigations are often limited by the lack of an efficient 
synthesis of each probe. Due to the absence of a modular approach in many of the 
syntheses, obtaining a library of probes requires that each probe be synthesized in an 
individual manner, rather than through the derivatization of a common scaffold. 
Therefore, we sought to design a lipid scaffold containing a versatile, reactive tag that 
could be functionalized at a late stage in the synthesis in order to obtain a family of 
DAG-based probes. The choice of an appropriate reactive tag is crucial, as the tag 
modification must be tolerant of the other functional groups present in the lipid structure. 
For this purpose we chose to incorporate an azide functionality at the sn-1 position. The 
azide is a bio-orthogonal species that is easily modified via the 1,3-dipolar cycloaddition 
(“click” chemistry),38-40 a strategy that will not interfere with the core structure of the lipid.  
The initial azido-DAG target is represented by lipid 2.2.1 (figure 2.2). This 
compound not only serves as a scaffold for obtaining other, more complex probes 










  Before embarking on the actual synthesis of 2.2.1, there was one aspect that 
warranted consideration in the synthetic design. The migration of the sn-2 acyl chain to 
the sn-3 position is a common occurrence in lipid synthesis (figure 2.3).  The migration 
is known to be catalyzed via both acid and base mechanisms, as well as facilitated by 
prolonged exposure to silica gel.64 Therefore, deprotection of the sn-3 hydroxyl group 
must be done in a manner so as to avoid migration. Side reactions of the deprotection 
should also be minimized, as silica chromatography, which would be needed to purify 
the final product, must be performed rapidly. Ultimately three different approaches were 
designed and each carried out in order to obtain 2.2.1 and analogues thereof. 
The initial approach utilized the commercially available C2 symmetric tartrate 
2.4.2 as shown in figure 2.4. Following modified a literature procedure65 the diol of 2.4.2 
was protected with an acetonide to furnish 2.4.3 and subsequently reduced to generate 
bis-hydroxymethyl compound 2.4.4. Mono p-methoxybenzyl (PMB) protection of 2.4.4 
furnished known alcohol 2.4.5,66 which was converted to azide 2.4.6 via a Mitsunobu 
reaction. The acetonide protecting group was removed under acidic conditions to yield 
diol 2.4.7. Stearic acid was coupled to the hydroxyl groups to furnish the PMB-protected 
azido DAG 2.4.8a. Oxidative removal of the PMB protecting group to afford 2.2.1, 
however, also yielded migration byproduct 2.2.1a, as observed in the proton NMR 
(figure 2.5, table 2.1). Although this reaction has been used to produce a primary 
alcohol on a similar lipid structure with no reports of migration,32 when used in our 
synthesis, 2.2.1a was always produced as a byproduct. Previous accounts using this 
































Table 2.1. Percentages of 2.2.1 and 2.2.1a based upon analysis of 1H NMR 
spectra following PG removal. 
Protecting 
Group (PG) 





PMB (2.4.8a) Wet DDQ 85% 15% 
TBDPS (2.6.8b) TBAF 0% 100% 
TBDPS (2.6.8b) TBAF/AcOH 83% 17% 
1.00 1.17 
Larger integration 
due to migration 





















no modification at the sn-1position. We reasoned that replacing a hydrogen atom with 
the azido methyl may lead to the observed migration due to an increase in sterics.   
In an attempt to circumvent the migration of the sn-2 acyl chain to the sn-3 
position, a synthesis utilizing a silyl protecting group for the sn-3 hydroxyl group was 
designed as shown in figure 2.6. It is documented that removal of a silyl protecting 
group leads to reduced acyl migration in lipid synthesis.67 Mono tert-butyldiphenylsilyl 
(TBDPS) protection of 2.4.4 furnished 2.6.968, 69 which was then converted to azide 
2.6.10 via Mitsunobu conditions. The acetonide was removed under acidic conditions to 
provide diol 2.6.11, and coupling with stearic acid under standard ester forming 
conditions afforded TBDPS-protected azido DAG 2.6.8b. Removal of the silyl group was 
attempted via two forms of tetrabutylammonium fluoride (TBAF) deprotection as shown 
in table 2.1. Deprotection using only TBAF facilitated complete conversion to the 
migrated product 2.2.1a. While this could be reduced by addition of acetic acid 
(AcOH),67, 70 the percentage of migrated product present was comparable to that 
observed in the PMB-protection approach. 
These results indicate that the addition of the azidomethyl group at the sn-1 
position is responsible, at least in part, for the increased observance of migrated 
product, as we had originally theorized. Increasing the steric bulk at this position would 
promote the tendency for migration to occur for several reasones. First, migration would 
greatly alleviate steric strain in the molecule caused by having the azidomethyl group 
and the two large acyl chains in proximity. Second, the effective molarity of the 










removal of PMB and TBDPS groups occurs via basic mechanisms, which are also 
known to promote migration. The observation that both DDQ and TBAF neutralized with 
AcOH deprotections provided similar amounts of migrated product further indicates that 
some factor other than reaction conditions causes increased susceptibility of our system 
to furnish the migrated byproduct. 
At this stage we sought to design a synthesis utilizing a protecting group that 
could be removed very rapidly and under very mild conditions. Finally, the 
dimethoxytrityl (DMTr) protecting group was decided upon. This protecting group has 
been used in the protection of sn-3 hydroxyl groups,71 and is known to be removed 
under mildly acidic conditions.72 The synthesis for the DMTr protected scaffold is 
outlined in figure 2.7. Monotosylation of compound 2.4.4 furnished 2.7.12, which was 
directly converted to the azide 2.7.13.65, 73 Normally sn-3 the hydroxyl protecting group 
would be introduced at this point, but the DMTr would not survive the acidic conditions 
necessary to remove the acetonide. However, DMTr is selective for primary alcohols.72 
Therefore, acidic deprotection of the acetonide was used to access known azido-triol 
2.7.14,74 which was then converted to the DMTr compound 2.7.15. Introduction of 
stearate acyl tails using traditional ester forming conditions afforded DMTr-protected 
azido DAG 2.7.8c. A monomethoxytrityl (MMTr) analogue 2.7.8d was also synthesized, 
but ultimately, the DMTr synthesis was more efficient.  
After obtaining compounds 2.7.8c and 2.7.8d, a series of deprotection conditions 
were carried out as shown in table 2.2. Initially, MMTr deprotection with p- 





Figure 2.7. Synthesis of DMTr-protected azido DAG analogues. 
 
 
Table 2.2. Deprotection conditions for the trityl-protected azido DAG analogues. 
Protecting 





MMTr (2.7.8d) p-TsOH 0% 100% 
DMTr (2.7.8c) AcOH/p-ABA or pyrrole 98% 2% 
DMTr (2.7.8c) Cl2HCCOOH 0% 100% 






using dichloroacetic acid was attempted but also resulted in only 2.2.1a being obtained. 
Since a scavenger for the DMTr carbocation is always needed,75 and since the DMTr 
can be removed under milder conditions, a system of AcOH and pyrrole as the 
scavenger was utilized. Proton NMR analysis of the crude reaction mixture indicated no 
migration had occurred during the course of the reaction. After rapid chromatography, a 
mixture of 2.2.1 and 2.2.1a was obtained. Based upon NMR analysis, approximately 2% 
of 2.2.1a was present in the mixture. However, due to the rapid elution, reaction 
byproducts such as dimethoxytritylmethanol (DMTrOH) and the DMTr-pyrrole adduct 
were also recovered. More careful purification led to increased migration due to 
prolonged exposure to the silica gel. p-Aminobenzoic acid (p-ABA) was in turn used as 
the cation scavenger. It was reasoned that the carboxylate would prevent co-elution of 
the DMTr-p-ABA adduct, however, the DMTrOH still co-eluted with 2.2.1, and the NMR 
analysis for migration was similar to that observed with AcOH/pyrrole. While these 
results were drastically improved as compared to those observed with PMB and TBDPS 
synthetic routes, we still sought to develop a system that furnished no detectable 
migration. 
It was discovered that while the byproducts of the DMTr deprotection hinder 
purification of 2.2.1, they can be readily removed after “click” modification of 2.2.1. In 
order to achieve this, 2.7.8c was deprotected using AcOH/pyrrole and subsequent 
“click” reactions were carried out using a variety of functionalized alkynes, as shown in 
figure 2.8. The mild reaction conditions of the azide-alkyne cycloaddition did not 






















silica chromatography. The incorporation of the triazole ring also facilitated the 
purification of the final compounds. The aforementioned byproducts are considerably 
less polar than the functionalized product. Therefore, they are efficiently separated from 
the final compounds allowing rapid purification and minimal exposure to the silica. All 
final compounds were obtained in >99.5% 2.2.1 as analyzed by 1H NMR. The 1H NMR 
spectra of benzophenone analogue 2.8.16e obtained from the PMB route and from the 
DMTr route are shown in figure 2.9 as a comparison for the amount of migration 
produced by the two procedures.  
“Click” chemistry functionalization utilized a series of fluorescent (2.8.17a–d) and 
photoaffinity (2.8.17e) alkynes, which were accessed in one step from propargyl amine, 
to furnish the DAG analogues 2.8.16a–e. The fluorescent analogues (2.8.16a–d) were 
designed so as to include various FRET donors and acceptors. These probes will be 
utilized to study the multivalent interactions of DAG receptors. As FRET is highly 
dependent upon distance, any change in the proximity of the donor and acceptor upon 
binding should be visualized by monitoring the fluorescence signals. This will provide 
valuable insight as to how the receptor interacts not only with the ligand, but also the 
membrane. DAG probe 2.8.16e was functionalized with a benzophenone to serve as a 
photoaffinity label. This probe will be used towards the process of mapping the binding 







Figure 2.9: 1H NMR comparison of analogue 2.8.16e obtained through the PMB 
and DMTr synthetic routes. Only the region containing resonances corresponding 


















Biological Evaluation of DAG Analogues 
Having developed a series of DAG analogues, we next sought to determine how 
effective each probe would be in the monitoring of DAG-binding events. In order to 
analyze this, we monitored the binding of each analogue with PKCδ, a well known DAG 
receptor. In collaborative efforts with Dr. Robert Stahelin, surface plasmon resonance 
(SPR) equilibrium binding analysis was performed. Vesicles composed of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoserine (POPS), and DAG (78:20:2, respectively) were used as an active 
binding surface alongside vesicles containing only POPC as a control. sn-1,2-
Dioleoylglycerol (DiC18) served as a reference standard, as binding of PKCδ to vesicles 
containing this lipid are well documented.61 Liposomes containing DiC18 bound PKCδ 
with a Kd of 24nM as indicated in table 2.3 and figure 2.10. In identical fashion, DAG 
analogues 2.8.16a–e were incorporated into vesicles with POPC and POPS, and their 
ability to bind PKCδ was analyzed. Naphthyl analogue 2.8.16a displayed the lowest Kd 
(16 nM) and the 5(6)-carboxyfluorescein analogue 2.8.16d displayed the highest (28 
nM). However, the Kd values, as well as the binding isotherms, indicate that each DAG 
probe can effectively bind this DAG receptor. This data also confirms that the sn-1 
position is an acceptable location for the placement of a reporter molecule. The tag is 
placed as close to the binding motif as possible to facilitate optimal detection, yet still far 







Table 2.3. Binding properties of PKCδ with different DAG analogues. 
Lipid 
Kd (nM) using 
POPC/POPS/DAG 
(78:20:2) 
DiC18 24 ± 4 
Synthetic DiC18 19 ± 2 
Naphthyl-DAG (2.8.16a) 16 ± 3 
Dansyl-DAG (2.8.16b) 20 ± 3 
Coumarin-DAG (2.8.16c) 18 ± 2 
5(6)-CBF DAG (2.8.16d) 28 ± 5 








Figure 2.10. Affinity of PKCδ for DAG-containing membranes determined by SPR 
analysis. SPR measurements were used to determine Kds of PKCδ for 
POPC/POPS/DAG (78:20:2) vesicles where DAG represents synthetic DAGs reported 
above. PKCδ was injected at varying concentrations at a flow rate of 5 μL/min and the 
subsequent association and dissociation were monitored.  From these plots, the 
saturation response (Req, equilibrium value) was determined.  In order to calculate the 
Kd of PKCδ for the DAG containing vesicles, the equilibrium value (saturating response 
(Req) of protein bound) determined from each sensorgram was then plotted versus 
respective protein concentration (2, 5, 10, 20, 40, 80, 160, and 320 nM).  The solid lines 
represent theoretical curves constructed from Rmax and Kd values determined by 
nonlinear least squares analysis of the isotherms using Req = Rmax/(1 + Kd/C).   
 
 
● Synthetic DAG 
□ Coumarin DAG 







All reagents were purchased from Aldrich or Acros and used as received. Dry solvents 
were obtained from a Pure Solv solvent delivery system purchased from Innovative 
Technology, Inc. Column chromatography was performed using 230 - 400 mesh silica 
gel purchased from Sorbent Technologies. NMR spectra were obtained using a Bruker 
AC250 spectrometer updated with a TecMag data collection system, a Varian Mercury 
300 spectrometer, and a Bruker Avance 400 spectrometer. Mass spectra were obtained 
with JEOL DART-AccuTOF spectrometer with high resolution capabilities. Optical 
rotation values were obtained using a Perkin-Elmer 241 polarimeter. HPLC data was 
obtained using an HP series 1100 HPLC with an Alltech Lichrosphere SI 60 5U column 
with HPLC grade solvents purchased from Fisher.  1-Palmitoyl-2-oleoyl-sn-glycero-3- 
phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS), and 
sn-1,2-dioleoylglycerol (DiC18) were purchased from Avanti Polar Lipids, Inc. (Alabaster, 
AL). 
 
Experimental Procedure for the PMB Protection Synthesis 
((4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)dimethanol (2.4.4). A solution of diethyl-
L-tartrate 2.4.2 (6.76 mL, 39.5 mmol) and p-toluenesulfonic acid (128 mg, 0.672 mmol) 
in benzene (80 mL) was prepared in a flame-dried round-bottom flask. To the solution 
was added with stirring 2,2-dimethoxypropane (6.03 mL, 48.6 mmol). The solution was 




solution was allowed to cool to room temperature, at which point sodium carbonate (200 
mg, 1.89 mmol) was added and stirring was continued for 2 h. The solution was filtered 
and concentrated on a rotary evaporator to yield crude 2.4.3. 
A solution of lithium aluminum hydride (3.0 g, 79 mmol) in anhydrous THF (70 mL) was 
prepared in a flame-dried, 3-neck round-bottom flask. The suspension was cooled to 0 
°C and kept under nitrogen. The crude mixture containing 2.4.3 was dissolved in 
anhydrous THF (20 mL) and added dropwise to the reaction over 30 minutes. The 
reaction mixture was stirred at 0 °C for 1 h, then at room temperature for 1 h and was 
then cooled back to 0 °C. The reaction was quenched by the dropwise addition of 3 mL 
water, 3 mL of 10% NaOH, and 9 mL more of water. Vigorous stirring was continued for 
20 minutes while the mixture returned to room temperature. Anhydrous magnesium 
sulfate was added with stirring for 1 h to dry the reaction. The reaction was filtered and 
the solvent was removed by rotary evaporation. Column chromatography with silica gel 
and a gradient solvent system of 3 to 5% methanol/dichloromethane afforded 2.4.4 as a 
clear oil (4.5 g, 70% over 2 steps). 
Characterizations matched previous reports.65 
1H NMR (250 MHz, CDCl3) δ 4.02–4.00 (m, 2H), 3.83–3.71 (m, 4H), 2.49–2.45 (m, 2H), 
1.44 (s, 6H). 
 
((4S,5S)-5-((4-Methoxybenzyloxy)methyl-2,2-dimethyl-1,3-dioxolan-4-yl)methanol  
(2.4.5). A modified literature procedure was used to prepare 2.4.5.66 A solution of 




prepared in a flame-dried round-bottom flask under nitrogen and cooled to 0 °C with 
stirring.  Diol 2.4.4 (658 mg, 4.06 mmol) was dissolved in anhydrous DMF (20 mL) and 
added dropwise. Stirring was continued at 0 °C for 10 min and then at room 
temperature for 20 min. At this point the reaction mixture was cooled to 0 °C and 4-
methoxybenzyl chloride (606 μL, 4.47 mmol) was added dropwise. The mixture was 
then stirred at room temperature overnight. The reaction was quenched with ~50 mL 
water, and the mixture was extracted with dichloromethane (2 x 50 mL). The organic 
layer was then dried with magnesium sulfate and filtered, and the solvent was removed 
by rotary evaporation. Column chromatography with silica gel and a gradient solvent 
system of 20 to 60% ethyl acetate/hexanes afforded 2.4.5 as a clear oil (908 mg, 79%). 
1H NMR (300MHz, CDCl3) δ 7.24 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 4.56–
4.47 (m, 2H), 4.05–3.99 (m, 1H), 3.94–3.88 (m, 1H), 3.79 (s, 3H), 3.78–3.63 (m, 3H), 
3.54–3.49 (m, 1H), 2.56–2.52 (m, 1H), 1.41 (s, 6H); 13C NMR (62.9 MHz, CDCl3) δ 
159.4, 129.6, 129.5, 113.9, 109.3, 79.8, 76.5, 73.4, 70.1, 62.5, 55.2, 27.0; HRMS [M-H]+ 
calcd: 281.13890, found: 281.13718. 
 
(4S,5S)-4-(Azidomethyl)-5-((4-methoxybenzyloxy)methyl)-2,2-dimethyl-1,3-
dioxolane (2.4.6). Alcohol 2.4.5 (589 mg, 2.09 mmol) was dissolved in dry THF (15 mL) 
along with triphenylphosphine (1.096 g, 4.18 mmol). The solution was placed under 
nitrogen and diisopropyl azodicarboxylate (810 μL, 4.18 mmol) was added with stirring. 
Diphenylphosphoryl azide (901 μL, 4.18 mmol) was dissolved in dry THF (5 mL) and 




solvent was removed with a rotary evaporator, and column chromatography with silica 
gel and a gradient solvent system of 10 to 20% ethyl acetate/hexanes afforded 2.4.6 as 
a clear oil (507 mg, 79%). 
1H NMR (300 MHz, CDCl3) δ 7.23 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 4.53– 
4.45 (m, 2H), 4.06–3.96 (m, 2H), 3.79 (s, 3H), 3.63–3.47 (m, 3H), 3.30–3.24 (m, 1H), 
1.45 (s, 3H), 1.41 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 159.4, 129.8, 129.3, 113.8, 
109.9, 78.1, 76.5, 73.2, 69.9, 55.2, 52.0, 27.0, 26.8;  HRMS [M-N2+H]
+ calcd: 
280.15488, found: 280.15483. 
 
(2S,3S)-1-Azido-4-(4-methoxybenzyloxy)butane-2,3-diol (2.4.7). Compound 2.4.6 
(820 mg, 2.67 mmol) was dissolved in THF (14 mL) and 1 N HCl (14 mL) was added. 
The reaction was stirred at room temperature for 48 h and was then quenched with 
saturated sodium bicarbonate. The mixture was then diluted with water (50 mL) and 
extracted with dichloromethane (2 x 50 mL).  The organic layer was then dried with 
magnesium sulfate and filtered, and the solvent was removed by rotary evaporation. 
Column chromatography with silica gel and a gradient solvent system of 50 to 90% ethyl 
acetate/hexanes afforded 2.4.7 as a clear oil (627 mg, 88%). 
1H NMR (250 MHz, CDCl3) δ 7.23 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 4.50–
4.40 (m, 2H), 3.79 (s, 3H) 3.79–3.72 (m, 2H), 3.55–3.53 (m, 2H), 3.37–3.33 (m, 2H), 
3.19 (b s, 1H), 3.06 (b s, 1H);  13C NMR (62.9 MHz, CDCl3) δ 159.5, 129.6, 129.5, 
114.0, 73.3, 71.7, 71.3, 70.2, 55.3, 53.6;  HRMS [M-N2+H]





(2S,3S)-1-Azido-4-(4-methoxybenzyloxy)butane-2,3-diyl distearate (2.4.8a). Diol 
2.4.7 (375.2 mg, 1.40 mmol) was dissolved in anhydrous dichloromethane (15 mL). 
With stirring was added stearic acid (1.194 g, 4.2 mmol), 4-dimethylaminopyridine (188 
mg, 1.54 mmol), and N,N-dicyclohexylcarbodiimide (866 mg, 4.2 mmol). The reaction 
was stirred at room temperature for 3 h at which point it was filtered. Column 
chromatography with silica gel and a gradient solvent system of 0 to 10% ethyl 
acetate/hexanes afforded 2.4.8a as a white solid (1 g, 89%). 
1H NMR (300 MHz, CDCl3) δ 7.22 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.34–
5.29 (m, 1H), 5.25–5.20 (m, 1H), 4.49–4.37 (m, 2H), 3.80 (s, 3H), 3.52–3.44 (m, 3H), 
3.37–3.31 (m, 1H), 2.34–2.29 (m, 4H), 1.63–1.58 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 
6.8 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 172.9, 172.8, 159.4, 129.5, 129.46, 113.9, 
73.0, 70.59, 70.55, 67.5, 55.2, 51.0, 34.3, 34.2, 32.0, 29.73, 29.69, 29.5, 29.4, 29.3, 
29.2, 25.0, 24.9, 22.7, 14.1;  HRMS [M-N2+H]
+ calcd: 772.64551, found: 772.64821. 
 
(2S,3S)-1-Azido-4-hydroxybutane-2,3-diyl distearate (2.2.1). Compound 2.4.8a (592 
mg, 0.740 mmol) was dissolved in dichloromethane (7 mL) and 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) (410 mg, 1.81 mmol) and water (700 μL, 10%) were 
added with stirring. Stirring was continued at room temperature for 6 h at which point 
the reaction was quenched with saturated sodium bicarbonate. The reaction mixture 
was extracted with dichloromethane (2 x 50 mL), and the organic layer was dried with 
magnesium sulfate and filtered.  The solvent was then removed by rotary evaporation. 




of volatile side products. Column chromatography with silica gel and a gradient solvent 
system of 0 to 20% ethyl acetate/hexanes afforded 2.2.1 and 2.2.1a as white solids 
(426 mg, 85% combined).   
 
Experimental Procedures for the TBDPS Protection Synthesis 
 ((4S,5S)-5-((tert-butyldiphenylsilyloxy)methyl-2,2-dimethyl-1,3-dioxolan-4-
yl)methanol  (2.6.9). Compound 2.4.4 (700 mg, 4.32 mmol) was dissolved in 
anhydrous THF (7.5 mL) and added dropwise to a solution of NaH (173 mg, 4.32 mmol, 
60% purity) in anhydrous THF (7.5 mL) at 0 °C under a nitrogen atmosphere. Sitrring 
was continued at that temperature for 30 minutes at which time tert-butyldiphenylsilyl 
chloride (1.12 mL,4.32 mmol) was added. Stirring was continued for 30 minutes and the 
reaction was quenched with water (30 mL). The product was extracted with ethyl 
acetate, dried with magnesium sulfate, and concentrated under reduced pressure. 
Column chromatography with silica gel and a gradient solvent system of 20 to 40% ethyl 
acetate/hexanes afforded 2.6.9 as a colorless oil (1.380 g, 80%). 
Characterization matches previous reports.68, 69  
1H NMR (300 MHz, CDCl3) δ 7.74–7.68 (m, 4H), 7.45–7.39 (m, 6H), 4.17–4.10 (m, 1H), 
4.04–3.98 (m, 1H), 3.89–3.77 (m, 2H), 3.70–3.66 (m, 1H), 2.61 (b s, 1H), 1.45 (s, 3H), 
1.43 (s, 3H), 1.10 (s, 9H). 
 
(4S,5S)-4-(Azidomethyl)-5-((tert-butyldiphenylsilyloxy)methyl)-2,2-dimethyl-1,3-




(12 mL) at room temperature was added diisopropyl azodicarboxylate (426 μL, 2.2 
mmol) and triphenylphosphine (577 mg, 2.2 mmol). Diphenylphosphoryl azide (474 μL, 
2.2 mmol) was dissolved in dry THF (3 mL) and added to the reaction which was stirred 
overnight at room temperature. After the reaction was complete the mixture was 
concentrated under reduced pressure and column chromatography with silica gel and a 
gradient solvent system of 0 to 10% ethyl acetate/hexanes afforded 2.6.10 as a pale 
yellow oil (380 mg, 81%). 
[α]D
296K -25.97 (c = 1.155, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.71–7.66 (m, 4H), 
7.49–7.39 (m, 6H), 4.20–4.15 (m, 1H), 4.02–3.96 (m, 1H), 3.87–3.73 (m, 2H), 3.63–3.57 
(m, 1H), 3.33–3.27 (m, 1H), 1.48 (s, 3H), 1.42 (s, 3H), 1.09 (s, 9H); 13C NMR (75 MHz,  
CDCl3) δ 135.5, 132.9, 132.8, 129.9, 129.8, 127.8, 109.7, 78.0, 77.6, 64.0, 52.2, 27.0, 
26.9, 26.8, 19.2; HRMS [M-N2+H]
+ calcd: 398.21514, found: 398.21530.  
 
(2S,3S)-1-Azido-4-(tert-butyldiphenylsilyloxy)butane-2,3-diol (2.6.11). Azide 2.6.10 
(350 mg, 0.822 mmol) was dissolved in 8 mL 90% acetic acid and heated at reflux for 
10 minutes. The reaction was then slowly cooled to room temperature and concentrated 
under reduced pressure and purified via column chromatography with silica gel and a 
gradient solvent system of 10 to 50% ethyl acetate/hexanes to afford 2.6.11 as a pale 
yellow oil (235 mg, 74%). 
[α]D
296K +5.21 (c = 0.845, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.69–7.65 (m, 4H), 7.47–
7.39 (m, 6H), 3.88–3.66 (m, 4H), 3.44–3.32 (m, 2H), 2.89–2.87 (m, 1H), 2.72–2.70 (m, 




127.9, 71.1, 70.9, 65.6, 53.6, 26.8, 19.1; HRMS [M+NH4]
+ calcd: 403.21654, found: 
403.21717.  
 
(2S,3S)-1-Azido-4-(tert-butyldiphenylsilyloxy)butane-2,3-diyl distearate (2.6.8b).  
Diol 2.6.11 (220 mg, 0.571 mmol), stearic acid (487 mg, 1.71 mmol), 4-
dimethylaminopyridine (209 mg, 1.71 mmol), and dicyclohexylcarbodiimide (353 mg, 
1.71 mmol) were combined in dichloromethane (8 mL). The reaction was stirred at room 
temperature overnight at which point it was filtered. Column chromatography with silica 
gel and a gradient solvent system of 0 to 10% ethyl acetate/hexanes afforded 2.6.8b as 
a white solid (524 mg, 100%). 
[α]D
296K -2.78 (c = 0.360, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.66–7.63 (m, 4H), 
7.47–7.36 (m, 6H), 5.43–5.38 (m, 1H),  5.23–5.18 (m, 1H), 3.78–3.67 (m, 2H), 3.55– 
3.39 (m, 2H), 2.34–2.26 (m, 4H), 1.62–1.61 (m, 4H), 1.27 (b s, 56H), 1.06 (s, 9H), 0.89 
(t, J = 6.0 Hz); 13C NMR (75 MHz, CDCl3) δ 172.8, 172.7, 135.6, 135.5, 132.8, 132.7, 
129.9, 127.8, 127.7, 72.0, 70.3, 62.0, 51.0, 34.2, 34.1, 31.9, 29.7, 29.65, 29.62, 29.5, 
29.35, 29.28, 29.26, 29.2, 29.1, 26.7, 24.84, 24.70, 22.7, 19.1, 14.1.   
 
(2S,3S)-1-Azido-4-hydroxybutane-2,3-diyl distearate (2.2.1). Compound 2.6.8b (57 
mg, 0.062 mmol) was dissolved in THF (2 mL). Acetic acid (3.5 μL, 0.062 mmol) and  
TBAF·3H2O (19.6 mg, 0.062 mmol) were each dissolved in THF (2 mL) and added 
successively to the reaction. The reaction was stirred at room temperature for 80 




extracted using a solution of 30 mL CHCl3, 20 mL MeOH, and 10 mL H2O. The bottom 
layer was kept and concentrated. Quick chromatography with a short column of silica 
gel and a gradient solvent system of 10 to 100% ethyl acetate/hexanes afforded 2.2.1 
and 2.2.1a as white solids (31.3 mg, 74%, 11% TBDPS byproduct that was not 
separable).   
 
Experimental Procedure for the DMTr Protection Synthesis 
((4S,5S)-5-(azidomethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol (2.7.13). Diol 
2.4.4 (990 mg, 6.10 mmol) was suspended in anhydrous dichloromethane (36 mL). With 
stirring was added silver (I) oxide (2.12 g, 9.15 mmol), tosyl chloride (1.28 g, 6.71 
mmol), and crushed potassium iodide (203 mg, 1.22 mmol). The reaction was stirred at 
room temperature for 2 hours at which point it was filtered through a short plug of silica  
using ethyl acetate as an eluant and concentrated under reduced pressure to afford 
crude 2.7.12. 
The crude solution of 2.7.12 was dissolved in anhydrous DMF (60 mL) and sodium 
azide (1.19 g, 18.3 mmol) was added. The reaction was heated to 85 °C and stirred 
overnight. The crude reaction was extracted with ethyl acetate, dried with magnesium 
sulfate, and concentrated under reduced pressure. Column chromatography with silica 
gel and a gradient solvent system of 20-60% ethyl acetate/hexanes afforded 2.7.13 as a 
colorless oil (934 mg, 82% over 2 steps). 
 Characterization matches previous reports.73 




3.37–3.31 (m, 1H), 2.39 (t, J = 6 MHz, 1H), 1.47 (s, 1H), 1.44 (s, 1H). 
 
(2S,3S)-4-azidobutane-1,2,3-triol (2.7.14). Alcohol 2.7.13 was dissolved in 10 mL of 
90% acetic acid. The solution was heated to reflux for 10 minutes and then slowly 
cooled to room temperature. Solvent was removed under reduced pressure and column 
chromatography with silica gel and 10% methanol/dichloromethane afforded compound 
2.7.14 as a yellow syrup (232 mg, 92%).  
1H NMR (300 MHz, CD3OD) showed removal of the acetonide protecting group.The Rf 
value by TLC analysis matched previous reports,74 and compound 2.7.14 was used 
without any further characterization. 
 
(2S,3S)-1-azido-4-((4,4'-dimethoxytrityl)methoxy)butane-2,3-diol (2.7.15). Triol 
2.7.14 (75.3 mg, 0.512 mmol) was dissolved in pyridine (5 mL), and a small amount of 
4Å MS was added to the reaction flask. With stirring, 4,4'-dimethoxytrityl chloride (260 
mg, 0.768 mmol) was added. The reaction was placed under nitrogen and stirred at 
room temperature overnight. The reaction was then filtered with dichloromethane, and 
the solvent was removed under reduced pressure at low temperature (45 °C). Column 
chromatography with silica gel and a gradient solvent system of 30-80% ethyl 
acetate/hexanes afforded 2.7.15 as a yellow oil (143 mg, 62 %). 
[α]D
296K -5.53 (c = 1.428, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.42–7.18 (m, 9H), 6.82 
(d, J = 8.7 Hz, 4H), 3.82–3.64 (m, 8H (OCH3 + 2 CHOH)), 3.38–3.18 (m, 4H), 2.98 (d,   




135.7, 135.5, 130.0, 128.02, 127.97, 127.0, 113.3, 86.7, 71.3, 70.7, 65.2, 55.2, 53.6; 
HRMS [M + Cl-]- calcd: 484.16392, found: 484.16204. 
 
(2S,3S)-1-azido-4-((4,4'-dimethoxytrityl)methoxy)butane-2,3-diyl distearate 
(2.7.8c). Diol 2.7.15 (289 mg, 0.643 mmol), stearic acid (549 mg, 1.93 mmol), 4-
dimethylaminopyridine (79 mg, 0.643 mmol), and dicyclohexylcarbodiimide (398 mg,  
1.93 mmol) were combined in dichloromethane (7 mL). The reaction was stirred at room 
temperature for 7 hours, at which point it was filtered with ethyl acetate. Column 
chromatography with silica gel and 10% ethyl acetate/hexanes afforded 2.7.8c as a 
white solid (546 mg, 86%). 
[α]D
296K +3.10 (c = 0.967, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.42–7.18 (m, 9H), 6.82 
(d, J = 8.7 Hz, 4H), 5.45–5.40 (m, 1H), 5.27–5.23 (m, 1H), 3.78 (s, 6H), 3.45–3.39 (m, 
1H), 3.31–3.19 (m, 2H), 3.11–3.06 (m, 1H), 2.39–2.22 (m, 4H), 1.67–1.54 (m, 4H), 1.26 
(b s, 56H), 0.88 (t, J = 6.6 Hz, 6H); 13C NMR (100.6 MHz, CDCl3) δ 172.8, 172.7, 158.6, 
144.3, 135.6, 135.4, 129.96, 129.90, 128.0, 127.9, 126.9, 113.2, 86.3, 71.2, 70.7, 61.7, 
55.2, 50.9, 34.4, 34.1, 32.0, 29.73, 29.69, 29.68, 29.67, 29.5, 29.4, 29.3, 29.28, 29.2, 
25.0, 24.8, 22.7, 14.1; [M + O2]
- calcd: 1013.70683, found: 1013.71083. 
 
(2S,3S)-1-Azido-4-hydroxybutane-2,3-diyl distearate (2.2.1). Compound 2.7.8c (35 
mg, 0.036 mmol) and p-aminobenzoic acid (49 mg, 0.360 mmol) were combined in 2 
mL of solvent in a ratio of  dichloromethane : acetic acid : water (1 : 8.5 : 0.5). The 




dichloromethane (50 mL) and dried with magnesium sulfate. The solvent was removed 
under reduced pressure. Column chromatography was carried out on a short plug of 
silica gel using 30% ethyl acetate/hexanes. Because compound 2.2.1 is known to 
undergo acyl chain migration on silica, purification was performed rapidly. As a result of 
not being able to carefully purify the reaction, 2.2.1 was not obtained in pure form, but 
the trityl adduct impurities did not effect the next reaction and were easily removed 
during purification of the subsequent DAG analogues.  
1H NMR (300 MHz, CDCl3) δ 5.33–5.30 (m, 1H), 5.12–5.07 (m, 1H), 3.68–3.61 (m, 2H), 
3.49–3.46 (m, 2H), 2.44–2.33 (m, 5H, OH buried), 1.66–1.60 (m, 4H), 1.26 (b s, 56H), 
0.88 (t, J = 6.3 Hz, 6H);  13C NMR (62.9 MHz, CDCl3) δ 173.7, 173.2, 72.5, 70.5, 60.8, 
51.1, 34.2, 32.0, 29.7, 29.5, 29.4, 29.3, 29.2, 25.0, 24.9, 22.7, 14.1;  HRMS [M-H2O + 
H]+ calcd: 662.58358, found: 662.58257.  
 
Experimental Procedures for Alkyne-Functionalized reagents  
 
Standard amide bond-forming coupling conditions were employed to obtain alkyne-
functionalized fluorescent and cross-linking groups.  Generally, the coupling reagent 
N,N-dicyclohexylcarbodiimide (DCC) was used to produce the highly non-polar alkyne 
conjugates.  For the more polar alkyne conjugates, such as fluorescein, other coupling 
reagents, exemplified by 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC), were used to avoid problems with separating the products from the urea 





Naphthyl alkyne (2.8.17a). 2-Naphthylacetic acid (100 mg, 0.537 mmol), N,N-
dicyclohexylcarbodiimide (166.2 mg, 0.806 mmol), 4-dimethylaminopyridine, (32.8 mg, 
0.269 mmol) and propargylamine (44 μL, 0.644 mmol) were dissolved in methylene 
 chloride  (6 mL). The reaction was stirred at room temperature in the dark overnight. 
The reaction was extracted with dichloromethane (2 x 50 mL) from water (50 mL), and 
the organic layer was dried with magnesium sulfate and filtered, and the solvent was 
removed by rotary evaporation. Column chromatography with silica gel and a gradient 
solvent system of 25 to 50% ethyl acetate/hexanes afforded 2.8.17a as a white solid (95 
mg, 79%). 
1H NMR (300 MHz, CDCl3) δ 7.87-7.81 (m, 3H), 7.73 (s, 1H), 7.54–7.47 (m, 2H), 7.39–
7.36 (m, 1H), 5.58, (b s, 1H), 4.02 (dd, J = 5.3, 2.6 Hz, 2H), 3.77 (s, 2H), 2.16 (t, J = 2.6 
Hz, 1H);  13C NMR (62.9 MHz, CDCl3) δ 170.5, 133.5, 132.6, 131.9, 128.8, 128.3, 
127.7, 127.7, 127.3, 126.4, 126.1, 79.4, 71.5, 43.6, 29.3;  HRMS [M+H]+ calcd: 
224.10754, found: 224.10790. 
 
Dansyl alkyne (2.8.17b). Compound 2.8.17b was synthesized according to a literature 
procedure76 using dansyl chloride (100 mg, 0.371 mmol), propargylamine (31 μL, 0.445 
mmol), and triethylamine (62 μL, 0.445 mmol). The reaction mixture was extracted with 
dichloromethane (2 x 50 mL) from water (50 mL), and the organic phase was then dried 
with magnesium sulfate and filtered.  Next, the solvent was removed by rotary 
evaporation. Column chromatography with silica gel and a gradient solvent system of 25 




Characterization agreed with previous literature reports.  HRMS [M+H]+ calcd: 
289.10107, found: 289.10202. 
 
Coumarin Alkyne (2.8.17c). Coumarin-3-carboxylic acid (191 mg, 1 mmol) was 
dissolved in dry DMF (10 mL) and HBTU (455 mg, 1.2 mmol) and hydroxybenzotriazole 
(162 mg, 1.2 mmol) were added. The sides of the reaction flask were rinsed with dry 
DMF (1 mL), and diisopropylethylamine (198 μL, 1.2 mmol) was added and stirred for 5 
min. Propargylamine (82 μL, 1.2 mmol) was dissolved in DMF (1 mL) and added to the 
reaction mixture, which was then allowed to stir in the dark at room temperature 
overnight. After the reaction was complete, DMF was removed on a rotary evaporator, 
and the residue was extracted with ethyl acetate (2 x 50 mL) from 10% sodium 
bicarbonate (50 mL).  The organic phase was then dried with magnesium sulfate and 
filtered, and the solvent was removed by rotary evaporation. Column chromatography 
with silica gel and a gradient solvent system of 20 to 70% ethyl acetate/hexanes 
afforded 2.8.17c as a pale yellow solid (161 mg, 71%). 
1H NMR (300 MHz, CDCl3) δ 9.01 (b s, 1H), 8.29 (s, 1H), 7.72–7.66 (m, 2H), 7.43–7.39 
 (m, 2H), 4.26 (dd, J = 5.1, 2.4 Hz, 2H), 2.28 (t, J = 2.4 Hz, 1H);  13C NMR (69.2 MHz, 
CDCl3) δ 161.4, 154.6, 148.8, 134.3, 129.9, 125.4, 118.6, 118.0, 116.7, 79.1, 71.6, 29.5; 
HRMS [M+H]+ calcd: 228.06607, found: 228.06633. 
 
5(6)-CBF alkyne (2.8.17d). Propargylamine (34.3 μL, 0.5 mmol), 4-




and 5(6)-carboxyfluorescein (226 mg, 0.6 mmol) were dissolved in a 1:1 mixture of dry 
DMF and dichloromethane (4 mL) at room temperature. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC, 115 mg, 0.6 mmol) was added. 
The reaction mixture was stirred at room temperature overnight in the dark. After the 
reaction was complete, the mixture was extracted with ethyl acetate (2 x 50 mL) from 2 
N HCl (50 mL), and the organic layer was dried with magnesium sulfate and filtered. 
The solvent was then removed by rotary evaporation. Column chromatography with 
silica gel and a gradient solvent system of 5 to 15% methanol/chloroform with 0.1% 
acetic acid afforded 2.8.17d as an orange solid (140 mg, 68%).  Note:  Since both 
isomers were present in the 1H NMR spectra for compounds 2.8.17d and 2.8.16d and 
the ratio of each isomer is unknown in the commercially available acid, integration 
values are not reported. 13C NMR data for compounds 2.8.17d and 2.8.16d are not 
reported due to poor solubility of the compounds and the complex nature of the spectra 
due to the isomeric mixture. 
1H NMR (300 MHz, CD3OD), δ 8.75 (b s), 8.52–8.43 (m), 8.22–8.07 (m), 7.93 (b s), 7.62 
 (s), 7.32–7.30 (m), 6.69–6.52 (m), 4.21 (d, J = 2.4 Hz), 4.08 (d, J = 4.08 Hz), 2.66 (t, J 
= 2.3 Hz), 2.56 (t, J = 2.3 Hz);  HRMS [M+H]+ calcd: 414.09776, found: 414.09632. 
 
Benzophenone alkyne (2.8.17e). A solution of 4-benzoylbenzoic acid (200 mg, 0.884 
mmol), N,N’-dicyclohexylcarbodiimide (273.5 mg, 1.33 mmol), and 4-
dimethylaminopyridine (54 mg, 0.442 mmol) was prepared in dry dichloromethane and 




reaction mixture was stirred at room temperature overnight in the dark. After the 
reaction was complete, the mixture was extracted with dichloromethane (2 x 50 mL) 
from water (50 mL), and the organic layer was dried with magnesium sulfate and  
filtered, followed by solvent removal. Column chromatography with silica gel and a 
gradient solvent system of 20 to 70% ethyl acetate/hexanes afforded 2.8.17e as a white 
solid (145 mg, 62%). 
1H NMR (300 MHz, CDCl3) δ 7.92–7.84 (m, 4H), 7.82–7.78 (m, 2H), 7.65–7.60 (m, 1H), 
7.53–7.48 (m, 2H), 6.37 (b s, 1H), 4.30 (dd, J = 2.6, 5.25 Hz, 2H), 2.32 (t, J = 2.6 Hz, 
1H);  13C NMR (62.9 MHz, CDCl3) δ 196.0, 166.4, 140.3, 137.0, 136.9, 132.9, 130.1, 
128.5, 127.1, 79.3, 72.0, 29.9;  HRMS [M+H]+ calcd: 264.10245, found: 264.10361. 
 
 
Experimental Procedures for Obtaining DAG Analogues Modified by "Click" 
Chemistry 
 
Compound 2.7.8c (1 eq) and pyrrole (2.05 eq) or p-ABA (10 eq) were dissolved in 2 mL 
of solvent consisting of  dichloromethane : AcOH : H2O (1 : 8.5 : 0.5). The solution was 
stirred at room temperature for 6 hours if using pyrrole or 12.5 hours if using p-ABA. 
The reaction was extracted with dichloromethane (2 x 25 mL) and dried with 
magnesium sulfate. The solvent was removed under reduced pressure. The crude 
residue containing unmigrated 2.2.1 was then dried under high vacuum for 1-3 hours 
and used directly in the click reactions as described below. 
 




mmol) were dissolved in dry THF (0.5 mL). Copper sulfate pentahydrate (16 mg, 0.064 
mmol) and sodium ascorbate (12.7 mg, 0.064 mmol) were added along with water (0.5 
mL). The reaction was stirred in the dark at room temperature overnight. The reaction 
was extracted with dichloromethane (2 x 50 mL) from water, and the organic phase was 
dried with magnesium sulfate, filtered and the solvent was removed by rotary 
evaporation. Column chromatography on a short plug of silica gel and a gradient solvent 
system of 50 to 100% ethyl acetate/hexanes afforded 2.8.16a as a white solid (29 mg, 
50% (2 steps)). 
[α]D
296K -11.0 (c = 0.963, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.82–7.77 (m, 3H), 7.69 
(s, 1H), 7.57 (s, 1H), 7.51–7.45 (m, 2H),7.36–7.33 (m, 1H), 6.30 (t, J = 5.7 Hz, 1H), 
5.55–5.50 (m, 1H), 5.02–4.97 (m, 1H), 4.54 (d, J = 6 Hz, 2H), 4.42 (d, J = 5.7 Hz, 2H), 
3.79–3.56 (m & s overlapped, 4H), 2.71 (b s, 1H), 2.38–2.24 (m, 4H), 1.64–1.51 (m, 
4H), 1.25 (b s, 56H), 0.88 (t, J = 6.2 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 173.4, 173.1, 
171.1, 144.9, 133.5, 132.5, 131.9, 128.9, 128.3, 127.71, 127.65, 127.2, 126.4, 126.1, 
123.3, 72.0, 70.0, 60.5, 50.3, 43.8, 35.0, 34.1, 33.9, 29.72, 29.68, 29.5, 29.4, 29.3, 29.2, 
29.1, 24.9, 24.8, 22.7, 14.1;  HRMS [M+H]+ calcd: 903.69386, found: 903.68995. 
 
Dansyl-DAG (2.8.16b). Alkyne 2.8.17b (16.4 mg, 0.057 mmol) and 2.2.1 (0.057 mmol) 
were dissolved in dry THF (0.5 mL). Copper sulfate pentahydrate (14.2 mg, 0.057 
mmol) and sodium ascorbate (11.3 mg, 0.057 mmol) were added along with water (0.5 
mL). The reaction mixture was stirred in the dark at room temperature overnight. The 




phase was dried with magnesium sulfate, filtered and the solvent was removed by 
rotary evaporation. Column chromatography on a short plug of silica gel and a gradient 
solvent system of 50 to 100% ethyl acetate/hexanes afforded 2.8.16b as a greenish 
solid (30 mg, 55% (2 steps)). 
[α]D
296K -12.2 (c = 1.01, CHCl3); 
1H NMR (300MHz, CDCl3) δ 8.55 (d, J = 8.7 Hz, 1H), 
8.27–8.24 (m, 2H), 7.58–7.50 (m, 2H), 7.43 (s, 1H), 7.19 (d, J = 7.5 Hz, 1H), 5.51–5.44 
(m, 2H, NH buried), 4.98–4.93 (m, 1H), 4.48 (d, J = 6 Hz, 2H), 4.18 (d, J = 6 Hz, 2H), 
3.79–3.58 (m, 2H), 2.89 (s, 6H), 2.64 (b s, 1H), 2.39–2.27 (m, 4H), 1.66–1.53 (m, 4H), 
1.25 (b s, 56H), 0.88 (t, J = 6.5 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 173.4, 173.2, 
151.9, 144.4, 134.4, 130.6, 129.8, 129.6, 129.5, 128.6, 123.3, 123.2, 118.7, 115.3, 72.0, 
69.8, 60.5, 50.2, 45.4, 38.7, 34.1, 33.9, 31.9, 29.72, 29.68, 29.5, 29.4, 29.3, 29.26, 29.2, 
29.1, 24.9, 24.8, 22.7, 14.1;  HRMS [M+H]+ calcd: 968.68739, found: 968.68743. 
 
Coumarin-DAG (2.8.16c). Alkyne 2.8.17c (12.7 mg, 0.056 mmol) and 2.2.1 (0.056 
mmol) were dissolved in dry THF (0.5 mL). Copper sulfate pentahydrate (14 mg, 0.056 
mmol) and sodium ascorbate (11.1 mg, 0.056 mmol) were added along with water (0.5 
mL). The reaction mixture was stirred in the dark at room temperature overnight. 
Solvent was removed, and column chromatography on a short plug of silica gel and a 
gradient solvent system of 20 to 100% acetone/chloroform afforded 2.8.16c as a tan 
solid (31 mg, 60% (2 steps)). 
[α]D
296K -14.6 (c = 1.224, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 9.29 (bs, 1H), 8.91 (s, 




(bs, 2H), 4.61–4.60 (m, 2H), 3.80–3.59 (m, 2H), 2.64–2.62 (m, 1H), 2.39–2.28 (m, 4H), 
1.65–1.53 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 6.6 Hz, 6H);  13C NMR (75 MHz, CDCl3) 
δ 173.4, 173.1, 161.8, 161.2, 154.5, 148.5, 144.8, 134.3, 129.8, 125.3, 123.3, 118.5, 
118.1, 116.7, 72.1, 70.0, 60.5, 50.3, 35.4, 34.1, 33.9, 31.9. 29.72, 29.67, 29.5, 29.4, 
29.3, 29.2, 29.1, 24.9, 24.8, 22.7, 14.2; HRMS [M+H]+ calcd: 907.65239, found: 
907.65176. 
 
5(6)-CBF DAG (2.8.16d). Alkyne 2.8.17d (19.8 mg, 0.048 mmol) and 2.2.1 (0.048 
mmol) were dissolved in dry THF (0.5 mL). Copper sulfate pentahydrate (12 mg, 0.048 
mmol) and sodium ascorbate (9.5 mg, 0.048 mmol) were added along with water (0.5 
mL). The reaction was stirred in the dark at room temperature overnight. Solvent was 
removed and column chromatography on a short plug of silica gel and a gradient 
solvent system of 30 to 100% acetone/chloroform afforded 2.8.16d as an orange solid 
(25 mg, 47% (2 steps)).  Note:  since both fluorescein isomers (5 and 6-carboxy) were 
present in the 1H NMR spectra for compounds 2.8.16d and 2.8.17d, and the ratio of 
each isomer is unknown in the commercially available acid, integration values are not 
reported. 13C NMR data for compounds 2.8.16d and 2.8.17d are not reported due to 
poor solubility of the compounds and the complex nature of the spectra due to the 
isomeric mixture. 
[α]D
296K -8.5 (c = 0.823, 1 Acetone : 1 CHCl3); 
1H NMR (300 MHz, CDCl3 : (CD3)2CO (1 : 
1)) δ 9.05 (b s), 8.60 (b s), 8.50 (b s), 8.33–8.30 (m), 8.24–8.21 (m), 8.04–8.01 (m) 7.91 




(m), 4.72–4.59 (m) 4.30–4.17 (m), 3.83–3.65 (m), 2. 39–2.18 (m), 1.62–1.43 (m), 1.27 
(b s), 0.88 (t, J = 6.3 Hz);  HRMS [M+H]+ calcd: 1093.68408, found: 1093.68461. 
 
Benzophenone-DAG (2.8.16e). Alkyne 2.8.17e (13.6 mg, 0.052 mmol) and 2.2.1 
(0.052 mmol) were dissolved in dry THF (0.5 mL). Copper sulfate pentahydrate (13 mg, 
0.052 mmol) and sodium ascorbate (10 mg, 0.052 mmol) were added along with water 
(0.5 mL). The reaction was stirred in the dark at room temperature overnight. The 
reaction was extracted with dichloromethane (2 x 50 mL) from wate,r and the organic 
phase was dried with magnesium sulfate, filtered, and the solvent was removed by 
rotary evaporation. Column chromatography on a short plug of silica gel and a gradient 
solvent system of 50 to 100% ethyl acetate/hexanes afforded 2.8.16e as a white solid 
(34 mg, 69% (2 steps)). 
[α]D
296K -11.4 (c = 1.127, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 8.1Hz, 2H), 
7.84–7.73 (m, 5H), 7.61 (t,  J = 7.4 Hz, 1H), 7.49 (m, 2H), 7.33 (b s, 1H), 5.61–5.57 (m, 
1H), 5.06–5.01 (m, 1H), 4.77–4.71 (m, 2H), 4.62–4.59 (m, 2H), 3.81–3.75 (m, 1H), 
3.67–3.60 (m, 1H), 2.39–2.27 (m, 4H), 1.64–1.49 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 
6.6 Hz, 6H);  13C NMR (100.6 MHz, CDCl3) δ 195.9, 173.3, 173.2, 166.6, 144.7, 140.2, 
137.2, 137.0, 132.9, 130.1, 128.4, 127.1, 123.6, 72.1, 70.0, 60.6, 50.4, 35.4, 34.2, 34.0, 
31.9, 29.7, 29.5, 29.4, 29.3, 29.2, 29.1, 24.9, 24.8, 22.1, 14.1; HRMS [M+H]+ calcd: 






HPLC trace for functionalized DAG Probe 16b  
As discussed in the text above, the acyl chains of diacylglycerols are known to migrate 
in the presence of silica. NMR analysis of analogs obtained via removal of the PMB 
protecting group indicated that migration was occurring. Removal of the DMT group and 
direct modification via "click" chemistry followed by purification produced compounds 
with NMRs that showed virtually no migration. However, upon HPLC analysis, two 
peaks appeared (chromatogram for 2.8.16b shown below in figure 2.11), one for the 
migrated product and one for the unmigrated product. The same sample was 
reanalyzed by NMR after HPLC analysis and no migration was detected, leading to the 
conclusion that the migration was observed on the column. 
 
Protein Binding Analysis (This analysis was performed by our collaborator Dr. R. V. 
Stahelin at Indiania University School of Medicine-South Bend.) 
The DAG binding protein PKCδ was purified from Sf9 cells as previously described.61  
Lipid vesicles were prepared as previously described61 and consisted of 
POPC/POPS/DAG (78:20:2 where DAG is any synthetic DAG tested). POPC vesicles 
were prepared for the control surface. All surface plasmon resonance (SPR) 
experiments were performed at 25 °C using a Biacore X as described previously.77  
Equilibrium SPR measurements were carried out at the flow rate of 5 μl/min with coating 
of the L1 sensor chip (GE Healthcare) done as previously reported.77 After injecting 85 






































500 s, respectively. The sensorgrams were obtained using five or more different 
concentrations of the protein (within a 10-fold range of Kd) for each condition tested. 
The sensorgrams were corrected for refractive index change by subtracting the control 
surface response. The maximal response (Req, saturation value) was determined from 
the plots and then plotted versus protein concentrations (C). The Kd value was 
determined by a nonlinear least squares analysis of the binding isotherm using an 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3: Synthesis, Functionalization, and Biological Evaluations of 
Azide–Labeled Phosphatidic Acid (PA) Analogues for the Modular 




Background and Significance 
Phosphatidic acid (PA) is a phospholipid that consists of two acyl chains at the 
sn-1 and sn-2 positions and a phosphomonoester (phosphate group) at the sn-3 
position. PA is generated and consumed by different methods within the cell, depending 
upon the specific application for which it is to be used (Figure 3.1).6 One method for the 
generation of PA involves the reaction between glycerol 3-phosphate (G3P) and fatty 
acyl CoA. PA generated via this route constitutes biological stores of the lipid that are 
used in the synthesis of other lipids such as phosphatidylcholine (PC), 
phoshatidylserine (PS) and the phosphoinositides (PIPns).
5-7 PA can also be produced 
from other lipids, such as through the cleavage of the choline group from PC by 
phospholipase D (PLD) or the hydrolysis of various phospholipids to produce 
diacylglycerol (DAG), which is then phosphorylated by diacylglycerol kinases (DGK). PA 
that is produced via these processes is generally involved in signaling pathways and the 
recruitment of proteins to the membrane surface. Despite the simplicity of its structure, 
PA has emerged as an important signaling lipid involved in several physiological and 
pathophysiological processes.5-7, 79, 80 Interactions between these signaling lipids and 






Figure 3.1. Various synthetic routes of PA. This figure has been adapted from 
reference 6. Blue arrows indicate generation and consumption of PA for 











carcinogenesis through its indirect involvement with Ras enzymes.79, 80 
There are currently a number of known PA receptors6, 7 including protein 
kinases81-83, protein phosphatases84-86, and cAMP-specific phosphodiesterases.87, 88 By 
far, the best studied and characterized PA receptor is Raf-1 kinase. Binding of Raf-1 
kinase to PA facilitates association of the protein with the membrane, which brings it 
into proximity with Ras GTPase. This protein-protein interaction activates Raf-1 kinase 
and leads to the initiation of the Ras/Raf/MEK/ERK cell proliferation pathway89-96. It is 
also known that the C2 domain of certain protein kinase C isozymes, such as PKC 97 
and PKC ,98 have affinity for PA. Study of these interactions is important as the PKC 
family is known to be heavily involved in cancer.19, 58, 60 
Despite this recent increase in the number of known PA receptors, there is still 
much to be learned as to how a simple lipid such as PA can play such a profound role in 
cellular pathways, and bind receptors with such high specificity. de Kruijff and 
coworkers have proposed an electrostatic/hydrogen bond switch mechanism in 
attempts to explain these principles.99, 100 Monodeprotonated PA is stabilized by an 
intramolecular hydrogen bond that preserves the -1 charge. Basic residues in 
proteins/peptides are attracted to the negatively charged membrane surface through 
electrostatic interactions with the PA. Once bound to the surface, the basic side chains 
can form hydrogen bonds to the PA headgroup, which immediately leads to full 
deprotonation (-2 charge on PA). This increase in negative charge enhances the 
attractive forces between the amino acid and PA and results in the specificity related to 




receptors is the shape of PA.100 At physiological pH, PA exists as a cone-shaped lipid. 
As a result of its shape, PA lies below the membrane surface in the interfacial region 
which is mildly polar.23 This aspect is thought to enhance the penetration of hydrophobic 
residues into the membrane around the PA binding domain. Indeed, both aspects seem 
viable in terms of explaining the specificity observed for PA by its receptors as the PA 
binding domains in Raf-1 kinase,90, 91, 100 PKC ,97 and PKC 98 all contain basic amino 
acids that have been deemed crucial for PA recognition as well as hydrophobic residues 
that penetrate the membrane upon binding. 
Despite these advancements in understanding the actions of PA as a ligand, the 
full scope of PA-targeting proteins is not yet clear. The number of identified receptors is 
still relatively small compared to the biological processes that show PA-dependence. A 
primary complication in the discovery of PA-binding proteins is that these receptors 
generally do not possess conserved domains that can be employed for sequence 
homology searching.6, 7, 10 The PA binding domains established to date are diverse and 
consist of sequences that were not previously known the bind lipids.6, 7 In fact, the only 
common link that many of the PA binding domains share are small clusters of basic 
(Arg, Lys, Trp) amino acids.6, 7, 10, 100 However, this feature alone can not sufficiently 
explain the high specificity of these domains for PA over other lipids bearing negative 
charge.6, 7, 100 Such lipids are often significantly more abundant than PA and attempts at 
determining proteins that bind PA based solely on sequence holomogy searching often 
leads to the misidentification of PA receptors.6, 100  Due to this inability to discover PA-




elucidating binding interactions. As such, chemical probes are vital for studying and 
characterizing protein–PA binding interactions at the molecular level. Generation of 
probes from scratch has several benefits including the ability to purify to homogeneity at 
the end of the synthesis, the ability to incorporate reporter tags that will allow the 
investigation of the event in any way one chooses, and that it is often much more cost 
efficient than modifying natural lipids. Despite these advantages, the synthesis of lipid 
probes has been rarely pursued due to the required synthesis.32  
Synthetic PA probes have previously proven effective for probing receptors that 
target this lipid (figure 3.2). For example, Gadella and coworkers developed a caged PA 
analogue that was used to induced flagellar excision in algae.101 Here, the introduction 
of a 2-nitrophenylethyl (NPE) caging moiety allowed the probe to cross the membrane, 
and photolysis produced an increase of PA within the cell that caused a decrease in the 
swimming of the algae. In this case, commercially available lipids were used as 
precursors to the caged probes. Picq and coworkers developed a photoaffinity-tagged 
PA probe that was used in the covalent labeling of type 4 cAMP-phosphodiesterases 
(PDE4).30 The photoaffinity label was incorporated into the acyl tails, which is effective 
for proteins that interact significantly with lipid chains buried within the hydrophobic 
membrane core. Probe synthesis again utilized commercial lipids as precursors and 
enzymatic installation of the PA headgroup. Ktistakis and coworkers have designed a 
fully synthetic PA probe that was attached to beads via an amine incorporated into the 
sn-1 acyl tail.28, 29 The resulting PA-functionalized resin was employed for affinity 











analysis of certain PA receptors, this particular probe can not be incorporated into a 
membrane-type environment, and therefore not all PA receptors will bind to it.6 
Stabilized derivatives of PA, such as fluoromethylene phosphonate analogues 
developed by Prestwich and coworkers, have been shown to be capable of activating 
the mTOR pathway.102 Schultz and coworkers have developed PA probes with terminal 
alkynes and cyclooctynes attached to the acyl tail, which have proven effective for the 
fluorescence labeling of lipids in cells.45  
While each example has proven capable of investigating PA activity through 
interactions with various receptors or monitoring its movement within the cell, a modular 
scaffold that will allow easy access to a wide range of PA probes still remains 
undeveloped. Also, based upon the results obtained with our DAG analogues, we feel 
that the sn-1 position is a prime location of the installation of a reporter molecule. 
Installation of such a tag at any location of the headgroup is a characteristic absent in 
each example presented above. 
 
Synthesis of PA-based Lipid Probes 
The development of lipid probes is crucial to further the understanding of protein-
lipid binding events, as such probes allow investigation of the binding on the molecular 
level via the incorporation of appropriate reporter molecules. Generation of these 
probes from scratch is particularly advantageous as it reduces the cost of the probe, 
allows the incorporation of an array of reporter molecules, and purification allows a 




synthesis of such probes is difficult, and therefore few accounts synthetic probes exist.32  
Following the development of an efficient and modular approach for 
diacylglycerol (DAG)-based probes,103 we sought to extend this same methodology 
towards the synthesis of a litany of PA-based probes from a common scaffold (3.3.1), 
as shown in figure 3.3. However, initial attempts at direct installation of a protected 
phosphate headgroup onto the DAG scaffold proved to be problematic. The 
phosphoramidite chemistry used to install the phosphate headgroup is not as mild as 
the “click” chemistry used for DAG modification. Thus, a significant amount of sn-2 to 
sn-3 acyl migration was observed, forcing us to redesign the synthesis so as to 
incorporate the headgroup prior to introducing the acyl tails. 
In order to install the headgroup early in the synthesis, we initially attempted to 
utilize intermediate 2.7.13 from the DAG synthesis as shown in figure 3.4. However, 
phosphotriester 3.4.3 was difficult to purify due to co-elution with byproducts. 
Furthermore, acidic removal of the acetonide protecting group afforded only 
approximately 10% of diol 3.4.4. Presumably, the electron withdrawing properties of the 
phosphotriester deter protonation of the oxygen during the first step of the deprotection. 
Attempts at forcing the deprotection, such as heating in 90% acetic acid, led to 
decreased yields and decomposition of the phosphotriester. In order to circumvent the 
low yield, we turned our focus towards other 1,2-diol protecting groups that are more 
efficiently cleaved. 
The new approach, shown in figure 3.5, began with commercially available 





Figure 3.3.  Scaffolds for DAG and PA lipids possessing an azide as a synthetic 











Figure 3.5. Synthesis of protected azido PA probes incorporating early 











3.5.5, the esters were reduced to provide the bis-hydroxymethyl intermediate 3.5.6.32, 103 
Mono-tosylation followed by direct conversion to the azide73, 103 furnished 3.5.7. The 
headgroup, which was protected as a phosphotriester, was installed using dibenzyl 
diisopropylphosphoramidite 3.4.2 to afford 3.5.8. Removal of the cyclopentylidene 
acetal under acidic conditions was then employed to generate diol 3.4.4 in 52% yield. 
The ester tails were then coupled on to the diol using standard coupling reagents to 
produce protected PA scaffold 3.5.9. 
While the cyclopentylidene acetal was a better choice of protecting group for the 
diol than was the acetonide, we sought to determine if it was the optimal choice. 
Therefore, a variety of protecting group strategies shown in figure 3.6 were attempted in 
hopes of improving the deprotection yield. Initially, the p-methoxybenzylidene (PMP) 
analogue 3.6.10 was synthesized. However, the m-CPBA oxidative conditions required 
to install the phosphotriester and afford compound 3.6.11 led to partial deprotection of 
the PMP group. The use of milder oxidants also facilitated partial deprotection. Focus 
was then turned towards the individual protection of each alcohol. Attempts at installing 
two p-methoxybenzyl (PMB) groups onto the diol of 2.4.2 to furnish 3.6.12 were 
unsuccessful due to steric hindrance and side product formation. While two silyl groups 
could be installed on the diol of 2.4.2 to yield 3.6.13 following literature procedures,104, 
105 they were subsequently removed during the reduction of the ester groups in attempt 
to access 3.6.14. While compounds 3.6.15106 and 3.6.17 could be synthesized, attempts 
at the bis-silylation of each to furnish 3.6.16 and 3.6.18, respectively, were again 






















diol protections tolerant of other functionalities present in the core structure, the decision 
to return to the cyclopentylidene acetal was made, as it was the most efficient approach 
attempted. 
Having developed an efficient synthesis for protected PA scaffold 3.5.9, we now 
sought to derivatize the core scaffold utilizing the reactive azide tag in order to obtain a 
litany of PA probes. Following the reasoning and methods set forth in the synthesis of 
DAG-based probes,103 we again chose to modify the azide via “click” chemistry. The 
route for obtaining PA probes via modification of 3.5.9 is outlined in figure 3.7. Initial 
introduction of a variety of reporter molecules was accomplished through cycloaddition 
of 3.5.9 with multiple alkynes (2.8.17a-c, e; 3.7.19d).103 The functionalized protected PA 
scaffolds 3.7.20a-e were then deprotected with bromotrimethylsilane (TMSBr) and ion 
exchange was performed to produce the ammonium salts of PA probes 3.7.21a-e. 
Functionalization prior to benzyl deprotection was determined to be optimal as benzyl 
deprotection followed by cycloaddition conditions produced no observed product 
(3.7.21a-e). Likewise, TMSBr deprotection of the benzyl groups was superior to 
hydrogenolysis for several reasons. First, the hydrogenolysis reactions never went to 
completion, even after prolonged reaction times. Second, it was observed that the 
benzophenone moiety was reduced to the corresponding alcohol under such conditions. 
Thus, TMSBr removal provided quick and efficient deprotection of the benzyl groups in 
one hour and maintained a uniform synthetic procedure for all PA probes 3.7.21a-e. 
This strategy was efficient in obtaining a variety of PA probes modified with fluorescent 

















































































(3.7.21d)) as well as a photoaffinity tag (benzophenone (3.7.21e)). The fluorescent 
analogues were designed such that various Förster resonance energy transfer (FRET) 
pairs were included. Since FRET is highly dependent upon the distance between donor 
and acceptor,46-50, 107-109 these probes will be highly useful in detecting changes in 
proximity of the molecules upon protein binding. Installation of the benzophenone tag 
will be utilized in photo-cross-linking studies51 in order to characterize and map binding 
sites of PA receptors.  
As discussed earlier, the primary hindrance to the discovery of new PA receptors 
is the lack of a consensus sequence of the PA binding domain. A common approach for 
the identification of new enzymes is activity based protein profiling (ABPP).110-118 In 
ABPP, probes are designed that target enzymes based upon their activity. As such, a 
multitude of new proteins can be targeted and identified from a complex mixture. Most 
ABPP probes contain a crosslinking group for attachment to the protein, along with a 
secondary reactive tag that allows detection or isolation of the covalently linked 
receptor–probe. New lipid receptors can be rapidly identified from the same complex 
mixture of proteins using a similar approach in which bifunctional lipid probes are 
designed. For example, de Kroon and coworkers have developed such probes derived 
from the structure of PC.27  Each probe contains a crosslinking group along with a 
secondary azide tag for chemical modification and purification/detection.  
Therefore, we sought to design a bifunctional probe utilizing the azido PA 
scaffold 3.3.1. Figure 3.8 outlines the synthesis of an alkyne (3.8.19f) that was utilized 



































































3.8.22 is subjected to hydrogenolysis to remove the carbobenzyloxy (Cbz) N-terminal 
protecting group, followed by coupling to 4-benzoylbenzoic acid to furnish intermediate 
3.8.23. Hydrolysis of the methyl ester followed by coupling with propargyl amine yielded 
alkyne 3.8.19f.  
Having installed the photoaffinity label for cross-linking capability and the alkyne 
for attachment to the azido PA scaffold, the next task was how to convert the tert-
butoxycarbonyl (Boc) protected lysine side-chain amine into an azide, which will be 
used as the secondary reactive tag. Several approaches are outlined in figure 3.9. 
Initially, the Boc group of 3.8.19f was deprotected and the amine was coupled to 
glycolic acid, which was subsequently reacted with 3.5.9 to afford 3.9.24. However, 
conversion of the alcohol to an azide via Mitsunobu conditions was deemed inefficient 
as inconsistent and low yields were observed. Next, following removal of the Boc group 
of 3.8.19f, the alkyne was directly reacted with 3.5.9 to provide 3.9.25. Amine 3.9.25 
was subjected to diazo transfer reaction conditions to convert the amine to an azide.119 
However, these conditions also led to decomposition of the phosphotriester. Knowing 
that we could access compound 3.9.25, it was reasoned that coupling of 3.8.19f 
following Boc-deprotection to an azido-carboxylic acid derived from compounds such as 
3.9.26 or 3.9.27 would provide a protected activity based PA probe. However, diazo 
transfer conditions afforded little to no azide from the corresponding amino acids.  
At this point, a viable synthesis was designed that is outlined in figure 3.10. Here, 
following Boc deprotection of 3.8.19f, the resulting amine was attached to 3.5.9 via 
























































was coupled onto the amine to furnish protected PA probe 3.10.20f. TMSBr 
deprotection of the benzyl groups provided the activity based PA probe 3.10.21f. 
 
 
Biological Evaluation of PA Analogues 
Having developed seven new PA-based probes, we next sought to evaluate their 
efficacy as ligands for known PA receptors. In order to do so, we monitored the binding 
the C2 domain of PKCα to vesicles containing each of the probes 3.7.21a-e, 3.10.21f. In 
collaborative efforts with Dr. Robert Stahelin, surface plasmon resonance (SPR) 
equilibrium binding analysis was performed using liposomes containing 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE), and PA (40 : 40 : 20) as an active surface for 
recruitment of the protein. Synthetic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidic acid 
(POPA) was used as a control standard as binding of PKCα-C2 to these vesicles is well 
documented.121 The observed Kd for PKCα-C2 to these vesicles was 440 ± 50 nM as 
shown in table 3.1. Systematic analysis of each of the probes 3.7.21a-e, 3.10.21f 
revealed Kds similar to that for POPA as shown in table 3.1 and figure 3.11.  
These results indicate that all of the synthesized probes are effective for 
recruiting this PA receptor as each displayed a Kd value no larger than two times that for 
synthetic version of natural PA. Along these lines, this data also confirms that the sn-1 
position is an acceptable location for the placement of a reporter molecule, as was also 
seen with the DAG analogs.103 The tag is placed as close to the binding motif as 




Table 3.1. Kd values obtained from binding of PKCα-C2 with vesicles containing 
different PA compounds. 




POPA 440 ± 50 
Azido PA 3.3.1 640 ± 140 
Naphthyl PA 3.7.21a 780 ± 50 
Dansyl PA 3.7.21b 800 ± 70 
Coumarin PA 3.7.21c 850 ± 120 
Rhodamine PA 3.7.21d 510 ± 90 
Benzophenone PA 3.7.21e 570 ± 150 
Bifunctional PA 3.10.21f 520 ± 80 
  
a
 Binding experiments conducted in 25 mM Tris HCl pH 7.4, 








Figure 3.11.  Afinity of the PKCαC2 domain for PA-containing membranes determined 
by SPR analysis.  SPR measurements were used to determine Kds of PKC-α C2 for 
POPC/POPE/PA (40:40:20) vesicles where PA represents synthetic PA analogues 
reported above.  PKCαC2 was injected at varying concentrations to generate a binding 
isotherm of resonance units bound (saturating response units) versus protein 
concentrations.  The solid lines represent a theoretical curve obtained based on Rmax 
and Kd values determined by nonlinear least squares analysis.  Error bars are indicative 
of the standard deviation calculated from three separate measurements. 
 
○ Dansyl PA 




not to significantly deter the binding event. While some of the probes displayed tight 
binding affinities (rhodamine (3.7.21d) and bifunctional PA probe (3.10.21f)) as 
compared to POPA, there seems to be no correlation at this point between structure 




All reagents were purchased from Aldrich or Acros and used as received. Dry solvents 
were obtained from a Pure Solv solvent delivery system purchased from Innovative 
Technology, Inc. Column chromatography was performed using 230 – 400 mesh silica 
gel purchased from Sorbent Technologies. NMR spectra were obtained using a Bruker 
AC250 spectrometer updated with a TecMag data collection system, a Varian Mercury 
300 spectrometer, and a Bruker Avance 400 spectrometer. High Resolution Mass 
spectra were obtained with JEOL DART-AccuTOF and ABI Voyager DE Pro MALDI 
spectrometers. Optical rotation values were obtained using a Perkin-Elmer 241 
polarimeter. HPLC data was obtained using an HP series 1100 HPLC with an Alltech 
Lichrosphere SI 60 5U column with HPLC grade solvents purchased from Fisher. Cbz-
Lys(Boc)-OMe was purchased from Chem-Impex International (wood Dale, IL). 1-
Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine (POPE), and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidic acid (POPA) were purchased from Avanti Polar Lipids, Inc. (Alabaster, 




2.8.17a-c, e were given in chapter 2. 
Synthetic Procedures 
(2R,3R)-diethyl 1,4-dioxaspiro[4.4]nonane-2,3-dicarboxylate (3.5.5). Fully protected 
tartrate 3.5.5 was obtained following a slightly modified literature procedure in which the 
synthesis of the enantiomer was described.32 Diethyl-L-tartrate 2.4.2 (4.05 g, 19.6 
mmol) was dissolved in toluene (130 mL). To this stirring solution was added 
cyclopentanone (8.7 mL, 98 mmol) and p-toluenesulfonic acid (373 mg, 1.96 mmol). A 
Dean–Stark trap was attached and the reaction was heated at 130 °C overnight. Solid 
sodium bicarbonate (329 mg, 20%) was added and stirring was continued for 10 min. 
The reaction mixture was filtered and the filtrate was condensed under reduced 
pressure. Column chromatography with silica gel and a gradient solvent system of 0–
20% ethyl acetate to hexanes afforded 3.5.5 as a yellow oil (4.19 g, 79%). 
Characterizations matched the enantiomer of 3.5.5 but for the change in sign of the 
optical rotation.32  
[α]D
296K – 31.5(c = 2.92, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 4.71 (s, 2H), 4.26 (q, J = 
7.2 MHz, 4H), 2.03–1.67 (m, 8H), 1.30 (t, J = 7.2 MHz, 6H); 13C NMR (75.5 MHz, 
CDCl3) δ 169.7, 123.3, 77.0, 61.9, 36.6, 23.5, 14.1; HRMS [M + H]
+ calcd: 273.13381, 
found: 273.13516. 
 
 (2S,3S)-1,4-dioxaspiro[4.4]nonane-2,3-diyldimethanol (3.5.6). Compound 3.5.6 was 
obtained using a procedure modified from reports of the enantiomer32 and a similar 




added dropwise to a solution of lithium aluminum hydride (700 mg, 18.36 mmol) in 
anhydrous THF at 0 °C under nitrogen. After the addition was complete, stirring was 
continued for 1 h at 0 °C and then at room temperature for an addition 1 h. The solution 
was cooled to 0 °C and the nitrogen was removed. Carefully, water (1 mL), 10% NaOH 
(1 mL), and water (2 mL) were added to quench the reaction. Stirring was continued for 
30 min at room temperature. Anhydrous magnesium sulfate was added and stirring was 
continued for 30 min. The solution was filtered and concentrated under reduced 
pressure. Column chromatography with silica gel and a gradient solvent system of 0–
10% methanol to ethyl acetate afforded 3.5.6 as a clear oil which solidified upon 
refrigeration (1.70 g, 99%). 
Characterizations matched the enantiomer of 3.5.6 but for the change in sign of the 
optical rotation.32  
[α]D
296K – 6.50 (c = 1.692, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 3.97–3.94 (m, 2H), 
3.81–3.69 (m, 4H), 2.30–2.05 (m, 2H), 1.89–1.60 (m, 8H); 13C NMR (75.5 MHz, CDCl3) 
δ 119.4, 78.0, 62.3, 37.4, 23.4; HRMS [M + H]+ calcd: 189.11268, found: 189.11238. 
 
 ((2S,3S)-3-azidomethyl)-1,4-dioxaspiro[4.4]nonan-2-yl)methanol (3.5.7).  Azide 
3.5.7 was obtained following procedures reported for similar compounds.73, 103 Diol 3.5.6 
(720 mg, 3.83 mmol) was suspended in dichloromethane (20 mL). With stirring, silver (I) 
oxide (1.33 g, 5.75 mmol), tosyl chloride (803 mg, 4.21 mmol) and finely crushed 
potassium iodide (64 mg, 0.383 mmol) were added. The resulting solution was stirred at 




acetate as the eluant. The filtrate was concentrated under reduced pressure, and then 
DMF (40 mL) and sodium azide (622 mg, 9.58 mmol) were added. The solution was 
stirred at 85 °C overnight, concentrated, extracted with chloroform (2 x 100 mL), dried 
with magnesium sulfate, and concentrated under reduced pressure. Column 
chromatography with silica gel and 50% ethyl acetate to hexane as eluant afforded 
3.5.7 as a clear oil (636 mg, 78%). 
[α]D
296K – 57.8 (c = 1.492, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 4.05–3.90 (m, 2H), 
3.81–3.62 (m, 2H), 3.55–3.51 (m, 1H), 3.30–3.33 (m, 1H), 2.65 (b s, 1H), 1.89–1.67 (m, 
8H); 13C NMR (75.5 MHz, CDCl3) δ 119.8, 78.5, 76.1, 62.0, 52.0, 37.3, 37.2, 23.5, 23.3;  
HRMS [M – N2 + H]
+ calcd: 186.11302, found: 186.11384. 
 
 ((2S,3S)-3-(azidomethyl)-1,4-dioxaspiro[4.4]nonan-2-yl)methyldibenzyl phosphate 
(3.5.8). Azido alcohol 3.5.7 (425 mg, 1.99 mmol) was dissolved in anhydrous 
dichloromethane. 1H-tetrazole (13.3 mL, 5.98 mmol, 0.45 M stock) was added and the 
solution was cooled to 0 °C under nitrogen. Dibenzyl diisopropylphosphoramidite (3.4.2, 
721 μL, 2.19 mmol) was then added dropwise. Stirring was continued for 10 min at 0 °C 
and then at room temperature for 1 h. At this point the reaction solution was cooled to 0 
°C and m-chloroperoxybenzoic acid (1.81 g, 5.98 mmol, 57% purity) was added and 
stirring was continued for 1.5 h. The reaction was quenched with the addition of 
saturated sodium bicarbonate, extracted with dichloromethane (2 x 100 mL), dired with 
magnesium sulfate, and concentrated under reduced pressure. Column   




3.5.8 as a pale yellow oil (803 mg, 85%). 
[α]D
296K – 24.3 (c = 1.68, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.42–7.32 (m, 10H), 
5.11–4.99 (m, 4H), 4.09–3.87 (m, 4H), 3.43–3.37 (m, 1H), 3.24–3.18 (m, 1H), 1.89–1.60 
(m, 8H); 13C NMR (75.5 MHz, CDCl3) δ 135.7, 135.6, 128.7, 128.6, 128.0, 120.2, 76.8, 
76.0, 75.9, 69.6, 69.5, 66.7, 66.6, 51.8, 37.3, 37.1, 23.5, 23.4; 31P NMR (121.5 MHz, 
CDCl3) δ 0.143; HRMS [M – N2 + H]
+ calcd: 446.17325, found: 446.17276. 
 
(2S,3S)-4-azido-2,3-dihydroxybutyl dibenzyl phosphate (3.4.4). Phosphotriester 
3.5.8 (1.07 g, 2.26 mmol) was dissolved in methanol (15 mL). With stirring was added p-
toluenesulfonic acid (43 mg, 0.226 mmol). The solution was stirred at room temp 
overnight and quenched with saturated sodium bicarbonate and extracted with 
chloroform (2 x 100 mL), dried with magnesium sulfate, and concentrated under 
reduced pressure. Column chromatography with silica gel and a gradient solvent 
system of 80-100% ethyl acetate to hexanes afforded 3.4.4 as a clear oil (482 mg, 
52%). 
[α]D
296K + 8.04 (c = 1.48, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.37–7.31 (m, 10H), 
5.05–5.02 (m, 4H), 4.04–4.00 (m, 2H), 3.72–3.69 (m, 2H), 3.43–3.26 (m, 4H); 13C NMR 
(75.5 MHz, CDCl3) δ 135.4, 135.3, 128.8, 128.7, 128.1, 70.2, 70.1, 69.9, 69.8, 69.7, 
68.54, 68.46, 53.3; 31P NMR (121.5 MHz, CDCl3) δ 0.928; HRMS [M – N2 + H]
+ calcd: 





(2S,3S)-1-azido-4-(bis(benzyloxy)phosphoryloxy)butane-2,3-diyl distearate (3.5.9). 
Diol 3.4.4 (482 mg, 1.18 mmol), stearic acid (1.01 g, 3.55 mmol), 
dicyclohexylcarbodiimide (732 mg, 3.55 mmol) and 4-dimethylaminopyridine (144 mg, 
1.18 mmol) were dissolved in dichloromethane (12 mL) and stirred at room temperature 
overnight. The reaction was filtered using ethyl acetate and concentrated under reduced 
pressure. Column chromatography with silica gel and a gradient solvent system of 10–
30% ethyl acetate to hexanes afforded 3.5.9 as a white solid (820 mg, 74%). 
[α]D
296K – 4.26 (c = 1.315, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.35–7.26 (m, 10H), 
5.20 (b s, 2H), 5.04–5.01 (m, 4H), 4.13–3.90 (m, 2H), 3.45–3.28 (m, 2H), 2.35–2.24 (m, 
4H), 1.65–1.58 (m, 4H), 1.26 (b s, 56H), 0.88 (t, J = 6.5 Hz, 6H);  13C NMR (75.5 MHz, 
CDCl3) δ 172.7, 172.6, 135.6, 135.5, 128.7, 128.6, 128.03, 127.99, 70.0, 69.9, 69.7, 
69.6, 69.5, 65.1, 65.0, 50.6, 34.0, 31.9, 29.72, 29.68, 29.5, 29.4, 29.3, 29.1, 24.81, 
24.78, 22.7, 14.1; 31P NMR (121.5 MHz, CDCl3) δ 0.038; MALDI–HRMS [M + Na]
+ 
calcd: 962.6358, found: 962.6332. 
 
Rhodamine-Alkyne (3.7.19d). Lissamine Rhodamine B sulfonyl chloride (141 mg, 
0.244 mmol) was dissolved in DMF (10 mL). Propargyl amine (17 μL, 0.244 mmol) and 
triethyl amine (170 μL, 1.22 mmol) were added with stirring. Stirring was continued in 
the dark at room temperature overnight at which time the solvent was removed under 
reduced pressure. Column chromatography with silica gel and a gradient solvent 





1H NMR (300 MHz, CDCl3) δ 8.74 (m, 1H), 8.13–8.10 (m, 1H), 7.37 (d, J = 8.1 Hz, 1H), 
7.15 (d, J = 9.3 Hz, 2H), 6.93–6.89 (m, 2H), 6.82–6.81 (m, 2H), 3.93 (d, J = 2.4 Hz, 2H), 
3.64 (q, J = 7.2 Hz, 8H), 2.44 (t, J = 2.5 Hz, 1H), 1.33 (t, J = 7.2 Hz, 12H); 13C NMR 
(62.9 MHz, CDCl3) δ 158.3, 157.4, 156.0, 146.6, 142.7, 134.4, 133.0, 130.7, 128.6, 
127.6, 114.5, 114.1, 96.2, 78.6, 73.5, 46.2, 32.8, 12.7; MALDI–HRMS [M + Na]+ calcd: 
618.1703, found: 618.1699. 
 
Benzophenone-Lys(Boc)-OMe (3.8.23). Cbz-Lys(Boc)-OMe (3.8.22, 535 mg, 1.36 
mmol) was dissolved in methanol (15 mL). Palladium (II) hydroxide (10% wt) was added 
with stirring. A hydrogen atmosphere was established and stirring was continued 
overnight. The reaction mixture was filtered through celite and washed with methanol 
and the solvent was removed under reduced pressure. The residue was dissolved in 
DMF (10 mL). With stirring 4-benzoylbenzoic acid (308 mg, 1.36 mmol), 4-
dimethylaminopyridine (199 mg, 1.63 mmol), and N-methylmorpholine (523 μL, 4.76 
mmol) were added. After 5 min EDCI·HCl (313 mg, 1.63 mmol) was added and stirring 
was continued 7 h. The solvent was removed under reduced pressure and column 
chromatography with silica gel and a solvent system of 50% ethyl acetate to hexanes 
afforded 3.8.23 as a white foam (561 mg, 88%). 
[α]D
296K + 8.89 (c = 5.544, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.96 ( d, J = 8.4 Hz, 
2H), 7.84–7.77 (m, 4H), 7.62 (t, J = 7.5 Hz, 1H), 7.52–7.47 (m, 2H), 7.26 (d, J = 7.5 Hz, 
1H), 4.81–4.77 (m, 2H), 3.78 ( s, 3H), 3.13–3.11 (m, 2H), 2.00–1.40 (m, 15H); 13C NMR 




130.20, 128.4, 127.2, 79.1, 52.7, 52.5, 40.0, 31.9, 29.7, 28.4, 22.6; HRMS [M - Boc + 
2H]+ calcd: 369.18143, found: 369.18007. 
 
Benzophenone-Lys(Boc)-Alkyne (3.8.19f). Compound 3.8.23 (561 mg, 1.20 mmol) 
was dissolved in methanol (5 mL). With stirring was added 2 N NaOH (5 mL). Stirring 
was continued 20 min and TLC analysis showed no starting material. The solution was 
neutralized with Dowex®50WX8–200 H+ resin to pH ~4. The solution was filtered and 
the filtrate concentrated under reduced pressure. The residue was washed with toluene, 
concentrated, and dried under high vacuum 5 h. The residue was then dissolved in 
dichloromethane (15 mL) and with stirring propargyl amine (99 μL, 1.44 mmol), 4-
dimethylaminopyridine (146 mg, 1.20 mmol), EDCI∙HCl (276 mg, 1.44 mmol) and N-
methylmorpholine (395 μL, 3.59 mmol) were added. Stirring was continued overnight at 
room temperature at which time the solvent was removed under reduced pressure. 
Column chromatography with silica gel and a gradient solvent system of 50–80% ethyl 
acetate to hexanes afforded 3.8.19f as a white solid (550 mg, 93%, 2 steps). 
[α]D
296K + 1.07(c = 0.935, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.96–7.92 (m, 2H), 
7.81–7.74 (m, 4H), 7.61–7.44 (m, 5H), 4.82–4.75 (m, 2H), 4.12–3.96 (m, 2H), 3.08–3.07 
(m, 2H), 2.19 (t, J = 2 Hz, 1H), 2.00–1.77 (m, 2H), 1.59–1.38 (m, 12H); 13C NMR (75.5 
MHz, CDCl3) δ 195.9, 171.8, 166.8, 156.2, 140.3, 136.9, 136.8, 132.9, 130.1, 130.0, 
128.5, 127.3, 79.3, 79.1, 71.7, 53.5, 40.1, 32.3, 29.6, 29.2, 28.4, 22.7;  HRMS [M – Boc 





General Procedure for Click Chemistry Derivatization to Produce 
Phosphotriesters 3.7.20a-e.  
 
Compound 3.5.9 and derivatized alkynes (2.8.17a-c, e; 3.7.19d) were dissolved in THF  
(1.5–2 mL). Copper sulfate pentahydrate and sodium ascorbate were added along with 
H2O (0.5 mL). The solution was stirred at room temperature overnight at which point the 
solvent was removed under reduced pressure. Column chromatography with silica gel 
afforded compounds 3.7.20a-e. Due to the amphipathic nature of the phosphotriesters, 
the integration values in the proton NMR did not always correspond to the exact correct 
value. However, they were always close. The values listed below correspond to the 
value that should be observed. Actual NMR copies are included that show the observed 
values. 
 
Naphthyl Phosphotriester (3.7.20a). Alkyne 2.8.17a (33.7 mg, 0.151 mmol), 3.5.9 
(141.6 mg, 0.151 mmol), copper sulfate pentahydrate (113 mg, 0.453 mmol), and 
sodium ascorbate (179 mg, 0.906 mmol) were utilized. Column chromatography with a 
gradient solvent system of 70–100% ethyl acetate to hexanes afforded 3.7.20a as a 
white solid (151 mg, 86%). 
[α]D
296K – 4.41 (c = 3.79, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.80–7.75 (m, 3H), 7.69 
(s, 1H), 7.48–7.43 (m, 3H), 7.36–7.33 (m, 11H), 6.52 (t, J = 5.4 Hz, 1H), 5.44–5.39 (m, 
1H), 5.03–4.97 (m, 5H(1 + 4 H)), 4.43–4.41 (m, 4H), 4.18–4.06 (m, 2H), 3.71 (s, 2H), 
2.29–2.18 (m, 4H), 1.56–1.48 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 6 Hz, 6H); 13C NMR 




128.7, 128.6, 128.1, 128.0, 127.96, 127.3, 126.2, 125.9, 123.5, 69.65, 69.57, 69.1, 
64.82, 64.81, 49.9, 49.8, 43.6, 34.9, 33.9, 33.8, 31.9, 29.71, 29.67, 29.5, 29.4, 29.3, 
29.12, 29.07, 24.8, 24.7, 22.7, 14.1; 31P NMR (121.5 MHz, CDCl3) δ 0.005; MALDI–
HRMS [M + Na]+ calcd: 1185.7355, found: 1185.7310. 
 
Dansyl Phosphotriester (3.7.20b). Alkyne 2.8.17b (33.4 mg, 0.116 mmol), 3.5.9 (109 
mg, 0.116 mmol), copper sulfate pentahydrate (87 mg, 0.348 mmol), and sodium 
ascorbate (138 mg, 0.696 mmol) were utilized. Column chromatography with a gradient 
solvent system of 50–80% ethyl acetate to hexanes afforded 3.7.20b as a green glass 
(121 mg, 85%). 
[α]D
296K – 4.40 (c = 1.796, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 8.7 Hz, 1H), 
8.29–8.25 (m, 2H), 7.53 (q, J = 7.9 Hz, 2H), 7.34 (b s, 11H), 7.18 (d, J = 7.2 Hz, 1H), 
5.52 (b s, 1H), 5.40–5.35 (m, 1H), 5.08–4.97 (m, 5H(1 + 4H)), 4.39-4.37 (m, 2H), 4.17–
4.05 (m, 4H), 2.89 (s, 6H), 2.30–2.21 (m, 4H), 1.56–1.50 (m, 4H), 1.25 (b s, 56H), 0.88 
(t, J = 6.6 Hz, 6H); 13C NMR (75.5 MHz, CDCl3) δ 172.6, 172.3, 151.9, 144.4, 135.45, 
135.46, 134.6, 130.5, 129.9, 129.6, 129.5, 128.7, 128.6, 128.5, 128.03, 127.99, 123.4, 
123.1, 118.8, 115.3, 69.7, 69.6, 69.1, 64.92, 64.86, 49.8, 45.4, 38.7, 33.9, 33.8, 31.9, 
29.72, 29.67, 29.5, 29.4, 29.29, 29.27, 29.13, 29.07, 24.8, 24.7, 22.7, 14.1; 31P NMR 
(121.5 MHz, CDCl3) δ -0.058; MALDI–HRMS [M + Na]






Coumarin Phosphotriester (3.7.20c). Alkyne 2.8.17c (36.1 mg, 0.159 mmol), 3.5.9 
(149.3 mg, 0.159 mmol) copper sulfate pentahydrate (119 mg, 0.477 mmol), and 
sodium ascorbate (189 mg, 0.954 mmol) were employed. Column chromatography with 
a gradient solvent system of 70–100% ethyl acetate to hexanes afforded 3.7.20c as a 
white solid (153 mg, 83%). 
[α]D
296K – 6.96 (c = 6.132, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 9.28–9.25 (m, 1H) 8.90 
(s, 1H), 7.69–7.64 (m, 2H), 7.58 (s, 1H), 7.41–7.34 (m, 12H), 5.49–5.44 (m, 1H), 5.09–
4.98 (m, 5H(1+4H)), 4.73–4.71 (m, 2H), 4.49–4.47 (m, 2H), 4.19–4.09 (m, 2H), 2.30–
2.22 (m, 4H), 1.57–1.42 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 6.5 Hz, 6H); 13C NMR 
(100.6 MHz, CDCl3) δ 172.5, 172.2, 161.7, 161.1, 154.5, 148.4, 144.9, 135.6, 135.5, 
134.2, 129.8, 128.7, 129.0, 125.3, 123.3, 115.5, 118.3, 116.7, 69.7, 69.2, 64.9, 49.9, 
35.5, 34.0, 33.8, 32.9, 29.7, 29.5, 29.4, 29.3, 29.2, 24.8, 24.7, 22.7, 14.1; 31P NMR 
(121.5 MHz, CDCl3) δ 0.027; MALDI–HRMS [M + Na]
+ calcd: 1189.6940, found: 
1189.6920. 
 
Rhodamine Phosphotriester (3.7.20d). Alkyne 3.7.19d (21.4 mg, 0.036 mmol), 3.5.9 
(34 mg, 0.036 mmol) copper sulfate pentahydrate (27 mg, 0.108 mmol), and sodium 
ascorbate (43 mg, 0.215 mmol) were used. Column chromatography with 10% 
methanol / chloroform as eluant afforded 3.7.20d as a pink solid (44 mg, 80%). 
No optical rotation was obtained due to the high propensity of the compound to stain; 1H 
NMR (300 MHz, CDCl3) δ 8.52 (s, 1H), 7.93–7.91 (m, 2H), 7.30 (b s, 12H), 7.10 (d, J =  




5H(1 + 4H)), 4.73–4.69 (m, 1H), 4.58–4.45 (m. 3H), 4.16 (s, 2H), 3.65–3.52 (m, 8H), 
2.21–2.18 (m, 4H), 1.47–1.45 (m, 4H), 1.31–1.20 (m, 68H), 0.88 (t, J = 6.6 Hz, 6H);  13C 
NMR (100.6 MHz, CDCl3) δ 172.6, 172.3, 159.0, 157.8, 155.7, 155.5, 147.4, 142.3, 
135.83, 135.76, 133.73, 133.67, 133.3, 129.6, 128.6, 128.5, 128.4, 128.0, 127.4, 127.2, 
125.1, 114.3, 113.7, 113.6, 95.6, 70.0, 69.9, 69.63, 69.57, 69.5, 69.4, 68.9, 65.2, 50.1, 
45.8, 38.8, 34.1, 33.9, 31.9, 29.7, 29.5, 29.4, 29.1, 24.8, 24.7, 22.7, 14.1, 12.6; 31P NMR 
(121.5 MHz, CDCl3) δ -0.247; MALDI–HRMS [M + Na]
+ calcd: 1557.8169, found: 
1557.8251. 
 
Benzophenone Phosphotriester (3.7.20e). Alkyne 2.8.17e (38 mg, 0.144 mmol), 3.5.9 
(123 mg, 0.131 mmol), copper sulfate pentahydrate (98 mg, 0.392 mmol), and sodium 
ascorbate (155 mg, 0.785 mmol) were used. Column chromatography with a gradient 
solvent system of 70–100% ethyl acetate to hexanes afforded 3.7.20e as a white solid 
(135 mg, 86%). 
[α]D
296K – 5.27 (c = 2.544, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.94 (d, J = 7.8 Hz, 2H), 
7.83–7.76 (m, 4H), 7.64–7.58 (m, 2H), 7.48 (t, J = 7.7 Hz, 3H), 7.33 (b s, 10H), 5.49–
5.43 (m, 1H), 5.11–4.96 (m, 5H(1 + 4H)), 4.78–4.71 (m, 2H), 4.55–4.49 (m, 2H), 4.19–
4.09 (m, 2H), 2.30–2.22 (m. 4H), 1.56–1.49 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 6.5 Hz, 
6H); 13C NMR (100.6 MHz, CDCl3) δ 195.8, 172.6, 172.2, 166.5, 140.1, 137.2, 137.1, 
135.54, 135.47, 132.8, 130.0, 128.6, 128.4, 128.0, 127.97, 127.1, 123.6, 69.7, 69.6, 
69.2, 64.9, 64.8, 50.0, 35.5, 34.0, 33.8, 31.9, 29.7, 29.5, 29.4, 29.3, 29.14, 29.10, 24.8, 





1203.7485, found: 1203.7488. 
 
Bifunctional Phosphotriester (3.10.20f). Alkyne 3.8.19f (84 mg, 0.171 mmol) was 
dissolved in dichloromethane (2 mL) and with stirring was added trifluoroacetic acid (2 
mL). Stirring was continued for 2 h and the solvent was removed under reduced 
pressure and placed under high vacuum for 2 h. The residue was dissolved in THF (1.5 
mL) and 3.5.9 (161 mg, 0.171 mmol) was added along with copper sulfate pentahydrate 
(43 mg, 0.171 mmol), sodium ascorbate (68 mg, 0.342 mmol), and H2O (0.5 mL). 
Stirring was continued overnight at room temperature at which point the solvent was 
removed under reduced pressure and placed under high vacuum 2 h. This residue was 
dissolved in anhydrous DMF (3 mL) and 6-azidohexanoic acid 3.10.28120 (32 mg, 0.205 
mmol) was added. 4-Dimethylaminopyridine (21 mg, 0.171 mmol), EDCI∙HCl (72 mg, 
0.376 mmol), and N-methylmorpholine (94 µL, 0.855 mmol) were added and stirring 
was continued overnight at room temperature at which point the solvent was removed 
under reduced pressure. Column chromatography with silica gel and a gradient solvent 
system of 30–50% acetone to chloroform afforded 3.10.20f as a white solid (110 mg, 
44%, 3 steps). 
[α]D
296K – 4.91 (c = 4.36, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.98 (d, J = 8.4 Hz, 2H), 
7.80 (t J = 8.4 Hz, 4H), 7.64–7.47 (m, 6H), 7.34 (b s, 10H), 6.16–6.12 (m, 1H), 5.47–
5.42 (m, 1H), 5.07–4.96 (m, 5H(1 + 4H)), 4.68–4.66 (m, 1H), 4.52–4.52 (m, 4H), 4.13– 
4.07 (m, 2H), 3.26–3.19 (m, 4H), 2.30–2.23 (m, 4H), 2.12 (t, J = 7.5 Hz, 2H), 1.96–1.84 




195.8, 173.2, 172.6, 173.3, 171.8, 166.7, 144.8, 140.3, 137.0, 135.5, 135.4, 132.9, 
130.1, 130.0, 128.72, 128.67, 128.4, 128.0, 127.96, 127.3, 123.3, 69.72, 69.67, 69.2, 
64.9, 53.6, 51.2, 49.9, 38.6, 36.4, 35.1, 34.0, 33.9, 31.9, 29.7, 29.6, 29.4, 29.3, 29.14, 
29.06, 28.6, 26.4, 25.2, 24.80, 24.76, 22.7, 22.5, 14.1; 31P NMR (121.5 MHz, CDCl3) δ -
0.254; MALDI–HRMS [M + Na]+ calcd: 1492.8999, found: 1492.9028. 
 
General Procedure for Deprotection of Phosphotriesters to Access PA Analogues 
3.3.1 / 3.7.21a-e / 3.10.21f.  
 
Phosphotriesters 3.5.9 / 3.7.20a-e / 3.10.20f were dissolved in dichloromethane at 0 °C 
under argon. Bromotrimethylsilane was added and stirring was continued at room 
temperature for 1 h. Solvent was removed under reduced pressure and the residue was 
placed on a high vacuum line to remove any residual solvents. Methanol (2 mL) was 
added and the solution was stirred at room temperature for 1 h. The solid that formed 
was collected via filtration. The solid was dissolved in methanol–chloroform (1:4) and 
extracted with 8 mM ammonium acetate. The organic layer was concentrated under 
reduced pressure to afford 3.3.1 / 3.7.21a-e / 3.10.21f. 
 
Azido PA (3.3.1). Azido phosphotriester 3.5.9 (65 mg, 0.069 mmol), dichloromethane 
(2.45 mL), and bromotrimethylsilane (0.55 mL) afforded 3.3.1 as a white solid (30 mg, 
56%). 
1H NMR (300 MHz, CDCl3 : CD3OD (1:1)) δ 5.29 (b s, 2H), 4.09 (b s, 2H), 3.61–3.52 (m, 




NMR showed no resonance in any solvent tried; MALDI–HRMS [M - NH4 + 2Na]
+ calcd: 
804.5238, found: 804.5143. 
  
Naphthyl PA (3.7.21a). Naphthyl phosphotriester 3.7.20a (67 mg, 0.058 mmol), 
dichloromethane (1.64 mL), and bromotrimethylsilane (0.36 mL) afforded 3.7.21a as a 
brownish solid (40 mg, 70%). 
31P NMR (121.5 MHz, CDCl3) δ 1.44; MALDI–HRMS [M - NH4 + 2Na]
+ calcd: 
1027.6235, found: 1027.6273. 
 
Dansyl PA (3.7.21b). Dansyl phosphotriester 3.7.20b (80 mg, 0.065 mmol), 
dichloromethane (1.64 mL) , and bromotrimethylsilane (0.36 mL) afforded 3.7.21b as a 
green solid (74 mg, quantative yield). 
31P NMR (121.5 MHz, CDCl3) δ 1.09; MALDI–HRMS [M - NH4 + 2Na]
+ calcd: 
1092.6171, found: 1092.6128. 
 
Coumarin PA (3.7.21c). Coumarin phosphotriester 3.7.20c (60 mg, 0.051 mmol), 
dichloromethane (1.64 mL), and bromotrimethylsilane (0.36 mL) afforded 3.7.21c as a 
white solid (40 mg, 78%). 
31P NMR (121.5 MHz, CDCl3) δ 1.39; MALDI–HRMS [M - NH4 + 2Na]
+ calcd: 





Rhodamine PA (3.7.21d). Rhodamine phosphotriester 3.7.20d (44mg, 0.029 mmol), 
dichloromethane (1.64 mL), and bromotrimethylsilane (0.36 mL) Column 
chromatography with silica gel and a solvent system of 7 chloroform : 2.5 methanol : 0.5 
water was necessary to purify the phosphate.  The resulting solid was dissolved in 
methanol–chloroform (1:4) and extracted with 8 mM ammonium acetate. The organic 
layer was concentrated under reduced pressure to afford 3.7.21d as a purple solid (34 
mg, 85%). 
31P NMR no resonance could be detected in any solvent tried; MALDI–HRMS [M - NH4 
+ 2Na]+ calcd: 1399.7049, found: 1399.6963. 
 
Benzophenone PA (3.7.21e). Benzophenone phosphotriester 3.7.20e (41.5 mg, 0.035 
mmol), dichloromethane (1.64 mL), and bromotrimethylsilane (0.36 mL) afforded 
3.7.21e as a pinkish white solid (26 mg, 73%). 
31P NMR (121.5 MHz, CDCl3) δ 1.25; MALDI–HRMS [M - NH4 + 2Na]
+ calcd: 
1067.6185, found: 1067.6116. 
 
Bifunctional Benzophenone/Azido PA (3.10.21f). Bifunctional benzophenone/azido 
phosphotriester 3.10.20f (52 mg, 0.035 mmol), dichloromethane (1.64 mL), and 
bromotrimethylsilane (0.36 mL) afforded 3.10.21f as a white solid (38 mg, 83%). 
31P NMR (121.5 MHz, CDCl3) δ 1.12; MALDI–HRMS [M - NH4 + 2Na]
+ calcd: 





PA Binding Analysis with Surface Plasmon Resonance. (This analysis was 
performed by our collaborator Dr. R. V. Stahelin at Indiania University School of 
Medicine-South Bend.) 
All surface plasmon resonance (SPR) binding measurements were performed at room 
temprature (25 C). PA lipid stocks were dissolved in a chloroform:methanol (80:20) 
mixture from which liposomes were prepared as POPC:POPE:PA (40:40:20) for 
different PA compounds. Aliquots of lipid mixtures to prepare a final concentration of 0.5 
mg/ml of vesicles were dried under nitrogen and rehydrated with 500 μl binding buffer 
(25 mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM CaCl2 and 1 mM DTT). Lipid solutions 
were vortexed for 15 min and sonicated for 15 min. Lipid vesicles were then passed 19 
times through a 100 nm polycarbonate membrane in an Avanti Mini-Extruder at room 
temperature. The liposome coating of the Pioneer L1 sensor chip (GE Healthcare) has 
been described in detail previously.78, 122 Briefly, the sensor chip surface was washed 
and then coated by injecting 85 µl of vesicles containing various analogs of PA at a 5 
µl/min flow rate to yield a response of 5,000 resonance units (RU). Each lipid layer was 
stabilized by injecting 10 µl of 50 mM NaOH three times at 100 µl/min flow rate. 
Typically, no decrease in lipid signal was seen after the first injection. Various 
concentrations of PKCα-C2 (within a 10-fold range of Kd) were injected to study the 
equilibrium binding and viability of synthetic analogs of PA. PKCα-C2 was expressed 
and purified as previously described.123 For Equilibrium SPR measurements, the flow 
rate was set at 10 µl/min to allow sufficient time for the association phase, which in turn 




three data sets for each PA analogue, Req values were plotted versus respective protein 
concentrations (C), and the Kd value was calculated by a non-linear
 least squares 
analysis of the binding isotherm using an equation, Req = Rmax/(1 + Kd/C),
78 where Rmax 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 4: Microplate-Based Analysis of Protein-Membrane Binding 
Interactions via Immobilization of Whole Liposomes via a Biotinylated 
Anchor 
 
Background and Significance 
The cellular membrane is often heavily involved in crucial intra- and extracellular 
recognition events that can be directly linked to a variety of important physiological and 
pathophysiological events.  The membrane surface is decorated with a litany of 
biological ligands such as phospoholipids, sphingolipids, carbohydrates, peptides, and 
embedded proteins that can interact with solubilized proteins (figure 4.1). These 
interactions directly correlate to a wide range of cellular processes including 
biomolecule synthesis or other cellular pathways. In addition, presentation of multiple 
ligands in a multivalent manner helps regulate receptor binding and function.20, 21 Due to 
prominent involvement in molecular recognition during biological processes, the 
detection of these interactions on the molecular level is of high interest. However, as 
mentioned above, the membrane represents a highly complex heterogeneous 
environment. This leads to difficulty in investigating interactions that occur on the 
membrane since ligands may interact with multiple receptors, and the mechanisms of 
receptor-ligand interaction are often diverse and complex. 
There are many mechanisms by which solubilized proteins can interact with the 



















surface leading to the interactions, as with the case of GM1 with pentavalent toxins.124 
Other proteins, such as Ras GTPases, may contain hydrophobic functionalities, such as 
post-translationally appended lipid tails. These will insert into the membrane bilayer and 
thus help regulate cellular location.80, 125, 126 Other proteins simply insert hydrophobic 
residues into the non-polar regions of the membrane. Such an example is the protein 
hemagglutinin (HA). Following anchoring of the influenza virus to the membrane via 
binding to sialic acid presented on the membrane, HA inserts into the membrane 
promoting membrane fusion and viral entry.127, 128 In addition, antimicrobial peptides 
such as gramicidin aggregrate on the membrane surface via a variety of mechanisms. 
This aggregration then promotes membrane insertion followed by pore formation or 
vesicle disruption.129, 130 
 An alternative manner in which proteins may interact with the membrane surface is 
through direct binding to lipids contained within the membrane, as discussed concerning 
DAG and PA in chapters 2 and 3, respectively. Such lipids are often present in small 
quantities and their expression is tightly controlled by the cell. Various proteins within 
the cell specifically bind to these lipids and are involved in a variety of cellular pathways. 
Their involvement in these processes, coupled with the finite aspects of the actual 
binding process, warrants the investigation of these events. As such, a high-throughput 
method of capable of analyzing a variety of receptors and their ability to bind membrane 
surfaces containing the signaling lipid would be beneficial. 




membrane penetration, and surface palsmon resonance (SPR) have been used in the 
investigation of protein-membrane binding events.131 However, such approaches do not 
lend themselves to high-throughput analysis due to various factors such as cost and 
methods of detection. Recently, a solution-phase turbidity assay was reported for the 
detection of protein-membrane binding.132 While effective as a high-throughput 
technique, drawbacks include using absorbance, which generally limits sensitivity, as 
the method of detection, and the fact that the receptor is dimerized in order to promote 
detection. This is potentially problematic as it may not represent the true structure of the 
receptor in biological systems. 
In order to obtain high-throughput capability and perform the analyses in an 
efficient manner, we sought to develop a microplate-based approach for monitoring 
PKC binding to DAG.  Microarray techniques have proven effective for characterization 
of events involving DNA,133, 134 carbohydrates,135-143 proteins and peptides,144-146 and 
more recently, lipids.147, 148 Microarray analysis has also been extended to the 
deposition of membranes onto surfaces to monitor integral membrane proteins.149, 150 
The immobilization of whole liposomes has generally been carried out by the 
incorporation of a biotinylated anchor into the membrane.52-56 With a few exceptions,151, 
152 membrane anchors have been accessed through the modification of 
phosphatidylethanolamine (PE). However, this is not an economically feasible or 
synthetically facile approach. Also, the biotin anchor needs to be presented at some 
distance from the membrane surface as liposomes are known to degrade upon contact 




design an efficient system that would allow immobilization of whole liposomes 
containing signaling lipids via a biotinylated anchor. In order to maintain cost efficient 
processes, all lipid analogues will be synthesized from scratch using inexpensive 
starting materials. In order to detect immobilization, a fluorophore-tagged lipid will be 
incorporated into the membrane. 
 
Synthesis of Functionalized Lipids  
Since two different lipid analogues, the biotin anchor and fluorophore-tagged 
lipid, needed to be synthesized, we sought to design a common scaffold so that each 
lipid could be accessed from a common precursor in a modular approach. This would 
allow quick and efficient changes in the design of the linker spacing the biotin from the 
surface, or in the fluorophore utilized in order to obtain the optimal system. As such, 
azido-lipid 4.2.2 (figure 4.2) was synthesized as reported.153 Modification of 4.2.2 also 
provides a headgroup polar enough to keep the anchor/fluorophore above the 
membrane surface, via formation of the triazole ring produced in the “click” reaction.  
Having developed an efficient scaffold that can be efficiently derivatized by “click” 
chemistry,38-40 attention was now turned towards development of a biotin-alkyne reagent 
that would react with 4.2.2 and serve as the biotin anchor lipid. An efficient synthesis of 
such a linker is outlined in figure 4.3.  Tetraethylene glycol 4.3.3 will serve as the basis 
for the linker that will space the biotin from the surface of the membrane. Here, 4.3.3 is 
converted to the mono-ethyl ester 4.3.4 in a similar approach to that previously 
























4.3.5. Direct reduction of the azide to an amine proved unsuccessful, but it was found 
that the azide of 4.3.5 could be reduced and converted to the Boc-protected amine 4.3.6 
in a single step.155 Hydrolysis of the ethyl ester under basic conditions furnished acid 
4.3.7, which was converted to alknye 4.3.8 through coupling with propargyl amine. 
Acidic removal of the Boc group of 4.3.8 followed by coupling with biotin-
pentafluorophenyl ester 4.3.9 afforded biotin-TEG-alkyne linker 4.3.10. Reaction of 
4.3.10 with 4.2.2 via “click” chemistry afforded biotin lipid analogue 4.4.1a (figure 4.4). In 
order to obtain the flourophore-tagged lipid that will serve as a means for detecting 
liposome immobilization, 5(6)-carboxyfluorescein (CBF) alkyne 2.8.17d was attached to 
4.2.2 to afford 4.4.1b. 
 
Immobilization of Whole Liposomes 
Having developed compounds 4.4.1a and 4.4.1b, which can be incorporated in vesicles 
and should effectively facilitate the immobilization and fluorescence detection of whole 
liposomes, we moved on to test the efficacy of this process (figure 4.5). Initially, 
unilamellar liposomes were formed using standard conditions. Vesicles composed of 
98% PC, which is used as a bulk component for membranes, and 1% each of 4.4.1a 
and 4.4.1b, were prepared (Sample A), along with control vesicles that contained no 
biotin anchor 4.4.1a (Sample B). The size of the vesicles was controlled via extrusion 
through a polycarbonate membrane with pores of 200 nm. Dynamic light scattering 
(DLS) was used to ensure a relative narrow polydispersity of vesicle size.  Both sets of 









































































Figure 4.5. Representation of immobilization and detection of liposomes with and 





Following incubation, the solution was removed, and the wells were thoroughly washed 
with buffer. Measuring the amount of fluorescence remaining after washing should give 
an indication as to how much immobilization occurred. This was carried out using a 
microplate reader. Results of multiple experiments showing standard error are given in 
figure 4.6. As can be seen from the graphs, the fluorescence of sample A increased as 
the concentration of liposomes incubated in the well was increased, indicating that  
immobilization of liposomes did indeed occur. Control sample B exhibited only a small 
amount of background fluorescence, which further confirms the notion that liposome 
immobilization is driven by biotin anchor 4.4.1a.  
In a subsequent study, we sought to determine the amount of biotin required for 
optimal immobilization. Having obtained positive and consistent results using 1% of 
biotin anchor 4.4.1a in the liposome, we were curious to see whether immobilization 
could be achieved using lower percentages of 4.4.1a. Here, liposomes comprised of 
varying percentages of 4.4.1a (0-2%), a constant 1% of CBF-lipid 4.4.1b for detection 
purposes, and the remaining percentages comprised of PC, were incubated with 
streptavidin-coated wells as before. Following incubation, the wells were washed 
thoroughly with buffer and then measured for fluorescence on a plate reader. The 
results are shown in figure 4.7. As can be seen from the graph, a plateau is reached 
between 0.25% and 0.5% of 4.4.1a indicating efficient immobilization can be achieved 
with small percentages of 4.4.1a. 
As stated earlier, vesicles are known to fuse to certain surfaces.52 To further 











































Liposomes: 98% PC, 1% 4.4.1a, 1% 4.4.1b 
Liposomes: 99% PC, 0% 4.4.1a, 1% 4.4.1b 












Figure 4.7. Results obtained after measuring fluorescence of immobilized 














































opposed to unraveling and fusion of the vesicles to the surface, we designed a dye-
leakage assay.156 In such an experiment, vesicles are prepared with 5(6)-
carboxyfluorescein encapsulated at a self-quenching concentration (50 mM). Following 
the removal of unencapsulated dye via size exclusion chromatography (SEC), minimal 
fluorescence of the liposomes will be observed. Liposomes were prepared with 1% of 
biotin anchor 4.4.1a, 99% PC, and encapsulated dye. Following incubation with avidin-  
coated surfaces, the fluorescence of the original sample was measured on a plate 
reader (figure 4.8a). Initial fluorescence was negligible and upon addition of 20% Triton 
X-100 detergent, the fluorescence signal drastically increased. A similar experiment was 
carried out, but this time, the wells were washed after incubation to remove any 
unbound liposomes (figure 4.8b). Again, initial fluorescence was minimal and upon 
addition of the detergent, the signal increased. The combination of these results and 
those in figure 4.6 and 4.8 indicated that the liposomes are remaining intact during 
incubation and efficient immobilization of the whole vesicle is achieved. 
 
Detection of PKCα-DAG Interactions using Whole Liposome 
Immobilization 
Knowing that we could successfully immobilize whole liposomes, we then 
focused on using the technique in order to detect the binding of a protein to a ligand 
present in the immobilized membrane. For initial studies, we chose to incorporate DAG 
as the lipid and use the well known DAG receptor PKCα. PKCα is a conventional 







Figure 4.8. Results obtained from vesicle leakage assay of immobilized 
liposomes. The results in experiment A were obtained without a wash after 
immobilization. In experiment B, a wash after the incubation of liposomes was 
performed so the signal only corresponds to immobilized liposomes.  
 

















































































dependent interaction with PS. Liposomes similar to those reported for efficient PKCα 
binding61, 122, 157 were prepared and included 1% of 4.4.1a, 2% DAG, 20% PS, and 77% 
PC. The resulting liposomes were immobilized onto streptavidin-coated surfaces and 
binding of PKCα was detected via a dual antibody approach as shown in figure 4.9. 
Following liposome incubation, PKCα was introduced to the well and allowed to 
incubate with the immobilized DAG-containing liposomes. Following removal of 
unbound protein, rabbit anti-PKCα followed by goat anti-rabbit IgG horseradish 
peroxidase (HRP) conjugate were introduced into the system. Following thorough 
washing, chemiluminescence using the HRP-tagged antibody was used to detect the 
amount of bound PKCα (figure 4.10). 
Results obtained were in agreement with those expected as the graph resembles 
a standard binding isotherm. In an effort to prove the immobilization/protein 
binding/detection results, we repeated the study employing liposomes that lack biotin 
anchor 4.4.1a. The low background obtained confirms the validity of the results. 
 
Development of an Immobilization Assay for the Detection of Lectin-
Carbohydrate Binding 
Having developed an efficient assay for the detection of DAG receptors through a 
liposome immobilization assay,153 we next sought to extend the same principles to 
design a carbohydrate-lectin based assay. The first step was designing a lipid modified 




one step reaction of azido-lipid 4.2.2 with mannose alkyne 
  





















































77% PC, 20% PS, 2% DAG, 1% 4.4.1a 







4.11.11, which was obtained through collaboration with Dr. David Baker, University of 
Tennessee, to afford 4.11.1c as shown in figure 4.11. Arrays utilizing the immobilization 
of mannose and detecting the binding of ConA have previously been reported.139 
Mannose lipid 4.11.1c was incorporated into liposomes comprised of 10% 4.11.1c, 1% 
biotin anchor 4.4.1a, and 98% PC. Liposomes were incubated with a streptavidin-
coated surface and then rinsed to remove unbound liposomes.  Next, fluorescein-
tagged Concanavalin A (ConA) was introduced at varying concentrations along with 
0.05% bovine serum albumin (BSA) as a blocking agent. As a control, ConA was also 
introduced to wells that had not been treated with liposomes. Initial results are shown in 
figure 4.12. As seen from the graph, there is a significant amount of background signal. 
Various attempts at altering the percentages of BSA and mannose-lipid 4.11.1c, along 
with varying the concentration of ConA, did not improve the results. 
In order to determine if the background is resulting from non-specific interactions 
of the liposomes with the avidin surface, liposomes with 1% 4.11.1c, 1% of CBF-lipid 
4.4.1b, and 98 % PC were introduced to wells, alongside liposomes with 0% 4.11.1c, 
1%, 4.4.1b, and 99% PC. In order to determine if the manganese ion that is required for 
ConA binding played any role in the non-specific interactions, duplicate analyses were 
conducted in the presence of low and high concentrations of Mn+2. As seen from the 
results in figure 4.13, fluorescence intensity increases with the addition of Mn+2 and with 
the addition of mannose-lipid 4.11.1c. However, a relatively small background could be 
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such, liposomes were prepared to include 5% 4.11.1c, 1% 4.4.1a, and 94% PC in buffer 
that completely excluded the Mn+2 and Ca+2 ions. These liposomes were incubated in 
streptavidin-coated wells and unbound liposomes were removed with washing. During 
the introduction of ConA, the Mn+2 and Ca+2 ions were introduced into the buffer as 
each is required for binding. Once again, high background signal was observed as 
shown in figure 4.14. 
Hoping that the non-specific binding observed could be diminished with complete 
exclusion of the Mn+2 and Ca+2 ions throughout the entire assay, fluorescein tagged 
Galanthus Nivalis lectin (GNL) was chosen as a substitute for ConA as it requires 
neither ion for binding. Liposomes containing 5% 4.11.1c, 1% 4.4.1a, and 94% PC were 
prepared and incubated with streptavidin-coated surfaces. Following removal of 
unbound liposomes, GNL was introduced at varying concentrations. Controls were 
simultaneously carried out by incubating GNL in wells that had not been exposed to 
liposomes. As before, a significant amount of nonspecific interaction was observed.  
Taking into account all the experiments, several factors may be responsible as to 
why the assay is not working as well as the DAG-PKCα. First, using a receptor tagged 
with a fluorophore generally leads to increased background due to difficulty in washing 
away all residual fluorescence. In order to circumvent this drawback, a more sensitive 
technique may be employed. For example, if an HRP-tagged lectin could be obtained, 
chemiluminescence could be used to detect binding. However, since the concentration 
of the HRP tag is equal to that of the protein, a dual antibody assay may be more 
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Second, since these lectins interact with mannose in a multivalent fashion, 
incorporating only 5-10% of the sugar may not be adequate for optimal binding. We 
believe that 10-15% mannose-lipid 4.11.1c is the maximum amount that can be 
efficiently incorporated into vesicles. Higher concentrations of the sugar could be 
expressed by attaching it to a PE analogue, as it is known PE can be incorporated at 
much higher percentages.158  
Third, the sugar may not be expressed far enough away from the membrane 
surface for optimal recognition by the receptor, as longer spacers have been reported 
for similar purposes.152 This could be overcome by spacing the sugar from the surface 
via a TEG-based linker, similar to that used in designing 4.4.1a.  
Lastly, it is known that mannose can interfere with the binding of biotin to 
streptavidin,159 and the sugar may be outcompeting the biotin leading to less sugar 
expressed and reduced binding. If this is the main reason for the observation of poor 
results, anchoring of the membrane surface would need to be achieved via alternative 
means. An alternative to this would be a reverse assay160-162 in which biotin-tagged 
lectin is immobilized, followed by incubation with liposomes containing mannose-lipid 










All reagents were purchased from Acros or Aldrich and used as received. Dry solvents 
were obtained from a Pure Solv solvent delivery system purchased from Innovative 
Technology, Inc. Column chromatography was performed using 230 - 400 mesh silica 
gel purchased from Sorbent Technologies. NMR spectra were obtained using a Bruker 
AC250 spectrometer updated with a TecMag data collection system, a Varian Mercury 
300 spectrometer or a Bruker Avance 400 spectrometer. Mass spectra were obtained 
with JEOL DART-AccuTOF and ABI Voyager DE Pro MALDI spectrometers. Optical 
rotation values were obtained using a Perkin-Elmer 241 polarimeter. L-α-
phosphatidylcholine (PC) and L-α-phosphatidylserine (PS) were purchased from Avanti 
Polar Lipids, Inc. (Alabaster, AL). Liposome extruder and polycarbonate membranes 
were obtained from Avestin (Ottawa, Canada). Microplate-based fluorescence 
measurements were performed using a BioTek Synergy 2 multi-detection microplate 
reader. Clear, white and black reacti-bind streptavidin high binding capacity (HBC) 
coated 96-well microplates were purchased from Pierce Biotechnology (Rockford, IL). 
PKC  and rabbit anti-PKC  antibody were purchased from Calbiochem (San Diego, 
CA). Goat anti-rabbit igG HRP-conjugate was purchased from Chemicon International 
(Temecula, CA). Supersignal ELISA femto maximum sensitivity substrate was 
purchased from Pierce Biotechnology (Rockford, IL). Characterization of 5(6)-






Ethyl 14-hydroxy-3,6,9,12-tetraoxatetradecanoate (4.3.4). In a 3-neck round bottom 
flask equipped with a bubbler, tetraethylene glycol 4.3.3 (43.2 mL, 250 mmol) was 
dissolved in anhydrous dichloromethane. Copper triflate (904.2 mg, 2.5 mmol) was 
added along with anhydrous tetrahydrofuran (7 mL). The solution was cooled to 0 °C 
and placed under a constant stream of nitrogen. Ethyl diazoacetate (5.3 mL, 50 mmol) 
was dissolved in anhydrous dichloromethane (34 mL) and added dropwise to the stirring 
solution. The solution was allowed to gradually warm to room temperature and stirring 
was continued overnight. The reaction was extracted with saturated NaCl and then 
washed with dichloromethane (100 mL). The combined organic layers were combined 
and dried with magnesium sulfate and filtered, and the solvent was removed under 
reduced pressure. Column chromatography with silica gel and a gradient solvent 
system of 0 - 10 % methanol/ethyl acetate afforded 4.3.4 as a yellow oil (8.9 g, 64%).  
1H NMR (300 MHz, CDCl3) δ 4.20 (q, J = 7.2 Hz, 2H), 4.15 (s, 2H), 3.73-3.54 (m, 16H), 
1.27 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 170.4, 72.6, 70.7, 70.54, 70.52, 
70.44, 70.43, 70.2, 68.5, 61.4, 60.6, 14.2; HRMS [M + H]+ cacld: 281.16003, found: 
281.15895  
 
Ethyl 14-azido-3,6,9,12-tetraoxatetradecanoate (4.3.5).  Alcohol 4.3.4 (1.02 g, 3.64 
mmol) and triethylamine (1.5 mL, 10.92 mmol) were dissolved in anhydrous diethyl 
ether (7 mL) at 0 °C under a nitrogen atmosphere. Methanesulfonyl chloride (285 μL, 




solution was allowed to gradually return to room temperature. Stirring was continued for 
a total of 1 h. At this point solvent was removed under reduced pressure. The residue 
was dissolved in anhydrous ethanol (10 mL) and sodium azide (239 mg, 3.68 mmol) 
was added. The reaction was stirred at reflux overnight. The reaction was extracted with 
dichloromethane (2 x 100 mL) and the organic layer was dried with magnesium sulfate, 
filtered and the solvent was removed under reduced pressure to yield pure 4.3.5 as a 
yellow oil (1.04 g, 93%).  
1H NMR (300 MHz, CDCl3) δ 4.22 (q, J = 7.2 Hz, 2H), 4.15 (s, 2H), 3.73-3.67 (m, 14H), 
3.40 (t, J = 4.8 Hz, 2H), 1.28 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 170.4, 
70.8, 70.65, 70.62, 70.57, 70.0, 68.7, 60.8, 50.6, 14.2; HRMS [M - N2 + H]
+ cacld: 
278.16036, found: 278.16152  
 
Ethyl 14-tert-butoxycarbonylamino-3,6,9,12-tetraoxatetradecanoate (4.3.6).  Azide 
4.3.5 (1.08 g, 3.55mmol) was dissolved in ethyl acetate. Di-tert-butyl dicarbonate (1.55 
g, 7.1 mmol), triethyl amine (990 μL, 7.1 mmol) and Palladium on carbon (110 mg) were 
added with stirring. The flask was evacuated and refilled with hydrogen three times and 
stirred at room temperature overnight. The reaction mixture was filtered through a pad 
of celite and the solvent was removed under reduced pressure. Column 
chromatography with silica gel and and a gradient solvent of 5 : 1 - 2 : 1 
chloroform/acetone with 0.1% triethylamine afforded 4.3.6 as a yellow oil (853 mg, 
63%).  




3.53 (m, 14H), 3.34-3.31 (m, 2H), 1.44 (s, 9H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 170.5, 156.0, 79.1, 70.8, 70.62, 70.57, 70.55, 70.51, 70.21, 68.7, 60.8, 
40.3, 28.4, 14.2; HRMS [M + H]+ calcd: 380.22844, found: 380.22788 
. 
14-tert-butoxycarbonylamino-3,6,9,12-tetraoxatetradecanoic acid (4.3.7).  
Compound 4.3.6 (379.4 mg, 1 mmol) was dissolved in methanol (2 mL) and 2M NaOH 
(2 mL) was added with stirring. The reaction was stirred 30 min. At this point Dowex® 
50WX8-200 H+ ion exchange resin was added until the pH was 4-5. The reaction was 
filtered and the solvent was removed under reduced pressure to afford 4.3.7 as a brown 
solid (340 mg, 97%).  
1H NMR (300 MHz, CDCl3) δ 5.40 (b s, 1H), 4.08 (s, 1H), 3.66-3.54 (m, 14H), 3.34-3.24 
(m, 2H) 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 174.3, 156.3, 79.0, 70.4, 70.1, 70.0, 
69.9, 69.4, 69.1, 40.1, 28.4; HRMS [M + H]+ cacld: 352.19714, found: 352.19869. 
 
N-(prop-2-ynyl)-14-tert-butoxycarbonylamino-3,6,9,12-tetraoxatetradecane 
carboxamide (4.3.8). Acid 4.3.7 (340 mg, 0.968 mmol), propargylamine (73 μL, 1.06 
mmol), 4-dimethylaminopyridine (DMAP, 118 mg, 0.968 mmol), and N-
Methylmorpholine (213 μL, 1.94 mmol) were dissolved in anhydrous N,N-
Dimethylformamide (9mL). The solution was cooled to 0 °C and stirred for 5 min. 1-
Ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC-HCl, 222 mg, 1.16 
mmol) was added and the reaction was stirred at room temperature overnight. Next, the 




gradient solvent system of 5 : 1 - 2 : 1 chloroform/acetone afforded 4.3.8 as a yellow oil 
(285 mg, 76%).  
1H NMR (300 MHz, CDCl3) δ 7.44 (b s, 1H), 5.08 (b s, 1H), 4.11-4.09 (m, 2H), 4.03 (s, 
2H), 3.70-3.53 (m, 14H), 3.33-3.31 (m, 2H), 2.24 (t, J = 2.3 Hz, 1H), 1.45 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 169.9, 156.0, 79.7, 79.2, 77.3, 71.2, 71.1, 70.6, 70.5, 70.3, 
70.24, 70.16, 40.3, 28.4, 28.3; HRMS [M + H]+ cacld: 389.22878, found: 389.22797. 
 
13-oxo-3,6,9,12-tetraoxa-14-azaheptadec-16-1-biotinamide (4.3.10). Synthesis of 
4.3.10 was carried out by another graduate student in our lab.153 Alkyne 4.3.8 (145 mg, 
360 μmol) was dissolved in 20 mL of dry DMF. Triethylamine was added to the solution, 
which was then stirred for 5 minutes. Biotin-pentafluorophenyl ester 4.3.9 (148 mg, 360 
μmol) was added and the solution was stirred at room temperature overnight.  The 
solvent was then removed by rotary evaporation and the product was purified by column 
chromatography with a solvent system of 100% acetone - 40% 
methanol/dichloromethane. This yielded 4.3.10 as a colorless oil (188 mg, 100%). 
[α]D
296K + 22.19 (c = 5.25, MeOH/CHCl3); 
1H NMR (300 MHz, CD3OD/CDCl3): δ 4.54 (m, 
1H), 4.34 (m, 1H), 4.08 (s, 2H), 4.04 (d, J = 2.4Hz, 2H), 3.72 (m, 8H), 3.68 (m, 4H), 3.60 
(t, J = 4.9Hz, 2H), 3.43 (m, 3H), 3.20 (m, 1H), 2.94 (dd, J1 = 12.9Hz, J2 = 4.8Hz, 1H), 
2.76 (d, J = 12.9Hz, 1H), 2.24 (t, J = 7.2Hz, 1H), 1.65 (m, 4H), 1.46 (q, J1 = 14.4Hz, J2 = 
7.2Hz, 2H); 13C NMR (100.6 MHz, CD3OD/CDCl3): δ 174.9, 171.0, 164.5, 70.3, 70.2, 
70.1, 70.0, 62.2, 60.5, 55.8, 40.3, 39.4, 39.2, 35.8, 28.6, 28.4, 25.7; MALD–HRMS [M + 






(4.4.1a) Synthesis of 4.4.1a was carried out by another graduate student in our lab.153 
(S)-3-azidopropane-1,2-diyl distearate (4.2.2, 25 mg, 38.9 μmol) and biotin-TEG-alkyne 
4.3.10 (20 mg, 38.9 μmol) were suspended in 1ml of THF. Copper iodide (7.4 mg, 38.9 
μmol) and N,N-diisopropylethylamine (13μl, 77.8 μmol) were added and the resulting 
solution was allowed to stir at room temperature for 18 hrs. Next, the solvent was 
removed and the product was purified by a short column using 12 g silica gel with a 
solvent gradient of 2%-15% methanol/dichloromethane to obtain 4.4.1a a white solid (20 
mg, 44%).  
[α]D
296K 12.53 (c = 1.5, CHCl3); 
1H NMR (300 MHz, CD3OD/CDCl3): δ 7.63 (s, 1H), 5.43 
(m, 1H), 4.66 (m, 1H), 4.54 (m, 1H), 4.39 (m, 6H), 4.05 (m, 2H), 3.68 (m, 12H), 3.56 (m, 
2H), 3.40 (m, 3H), 2.94 (d, J = 4.8Hz, 1H), 2.78 (m, 1H), 2.29 (m, 6H), 1.64 (m, 8H), 




(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid (4.4.1b). Synthesis of 4.4.1b was 
carried out by another graduate student in our lab.153  (S)-3-Azidopropane-1,2-diyl 
distearate (4.2.2, 58.6 mg, 0.0901 mmol) and 2-Oxo-N-(prop-2-ynyl)-5(6)-
carboxyfluoresceinamide (2.8.17d, 37.2 mg, 0.0901 mmol)103 were dissolved in 1:1 




sodium ascorbate (35.7 mg, 0.180 mmol) were added. The reaction was stirred at room 
temperature in the dark overnight at which point the solvent was removed under 
reduced pressure. Column chromatography with a gradient solvent system of 10-20% 
methanol/dichloromethane afforded 4.4.1b as a yellow solid (65.3 mg, 68%). Note:  
since both fluorescein isomers (5 and 6-carboxy) were present in the 1H NMR spectra 
for compound 4.4.1b, and the ratio of each isomer is unknown in the commercially 
available acid, integration values are not reported. 13C NMR data for compounds 4.4.1b 
is not reported due to poor solubility of the compound and the complex nature of the 
spectra due to the isomeric mixture. 
[α]D
296K 0.8 (C = 1.5, CHCl3); δ 8.82 (b s), 8.41-8.29 (m), 7.99-7.87 (m), 7.42-7.26 (m), 
7.12 (bs), 6.88-6.55 (m), 5.43 (b s), 4.74-4.58 (m), 4.38-4.30 (m), 4.11-4.08 (m), 3.72-
3.67 (m), 2.40-2.27 (m), 1.64-1.59 (m), 1.26 (b s), 0.88 (t, J = 6.5 Hz); MALDI–HRMS [M 
+ H]+ calcd: 1063.6730, found: 1063.6699. 
 
Mannose-lipid (4.11.1c). Mannose-alkyne 4.11.11 (26 mg, 0.119 mmol) and (S)-3-
azidopropane-1,2-diyl distearate 4.2.2 (93 mg, 0.143 mmol) were dissolved in THF (2 
mL). Copper sulfate pentahydrate (36 mg, 0.143 mmol) and sodium ascorbate (57 mg, 
0.286 mmol) were added along with water (0.5 mL). The reaction was stirred at room 
temperature overnight and the solvent was removed under reduced pressure. Column 
chromatography with silica gel and a gradient solvent system of 100% ethyl acetate to 
10% methanol-chloroform afforded 4.11.1c as a white solid (76.5 mg, 74%). 
[α]D
296K + 25.3 (C = 3.06, CHCl3); 




5.43 (b s, 1H), 4.81–4.76 (m, 1H), 4.65–4.63 (m, 2H), 4.36 (dd, J = 3.8, 12.2 Hz, 1H), 
4.09 (dd, J = 5.0, 11.9 Hz, 1H), 3.83–3.59 (m, 9H), 2.39–2.29 (m, 4H), 1.63–1.58 (m, 
4H), 1.26 (b s, 56H), 0.89 (t, J = 5.9 Hz, 6H) ; 13C NMR (100.6 MHz, CD3OD/CDCl3): δ ; 
MALDI–HRMS [M + Na]+ calcd: 890.6440, found: 890.6402. 
 
Liposome Immobilization Details 
General procedure for liposomes preparation. Solid lipids were dissolved in 
chloroform to a particular concentration and a specific amount of each lipid in solution 
was added to a small glass container. The chloroform was removed under a constant 
stream of nitrogen and the resulting lipid film was dried under vacuum overnight. The 
appropriate volume of buffer (20 mM HEPES, pH 7.4 for studies not involving PKC or 
100 mM NaCl, 20 mM HEPES, 1 mM CaCl2, pH 7.4 for studies involving PKC) was 
added to the dried lipids in order to produce a specific concentration of liposomes after 
hydration and size reduction. The suspension of lipid and buffer was agitated at 40 °C 
for 40 min and then subjected to 10 freeze-thaw cycles. Vesicles were prepared by 
extrusion (19 times) through a 200 nm polycarbonate membrane to control liposome 
size. 
 
Microplate liposome immobilization experiments. Analysis of liposome microplate 
immobilization was performed using either clear or black streptavidin-coated 
microplates. A solution of 20 mM HEPES buffer pH 7.4 was employed as the wash 




wash buffer for 30 minutes. This was removed, followed by introduction of 100 μL of the 
various liposome compositions at different concentrations. For the initial fluorescence 
immobilization study (Figure 1A), liposomes containing 98% PC, 1% 4.4.1a and 1% 
4.4.1b were analyzed alongside a control with 99% PC, 0% 4.4.1a and 1% 4.4.1b. To 
determine the optimal percentage of biotin for liposome surface attachment (Figure 1B), 
studies utilized different liposome samples containing 4.4.1b fixed at 1%, varying 
percentages of 4.4.1a (0-2%), and the rest of the liposome was made up of PC (98-
100%). After a one hour incubation, these solutions were removed and the wells were 
washed with 3 x 250 μL wash buffer. The microplate was then analyzed for 
fluorescence using a microplate reader with excitation using a 460 nm (± 40 nm) filter 
and emission detected with a 528 nm (± 20 nm) filter.   
 
Procedure for immobilized vesicle leakage assay.  Liposomes encapsulated with 
5(6)-carboxyfluorescein (CBF) were prepared following a procedure similar to those 
previously reported (52).  A solution of PC (99%) and biotin anchor 4.4.1a (1%) in 
chloroform was dried under vacuum 4 h.  The lipids were rehydrated with CBF buffer 
(50mM CBF, 20 mM HEPES, 150 mM NaCl, pH = 7.4) according to the general 
procedure cited above to give a final concentration of 5 mM liposomes.  Vesicles were 
prepared by extrusion (19 times) through a 200 nm polycarbonate membrane.  
Unencapsulated dye was removed using a Sephadex G-50 column equilibrated with 
buffer (20 mM HEPES, 150 mM NaCl, pH = 7.4).  Fractions containing liposomes were 




addition of 20 μL of 20% Triton X-100 to release the encapsulated CBF.  Analysis of 
liposome microplate immobilization was performed using black streptavidin-coated 
microplates.  Wells that were to be used for analysis were incubated with 200μL of was 
buffer (20 mM HEPES, 150 mM NaCl, pH = 7.4) for 30 min.  This was removed, 
followed by introduction of 100 μL of liposomes at various concentrations prepared from 
the combined fractions after SEC chromatography.  Incubation was carried out for 1 h.  
Following incubation, subsequent analysis was performed both with (Figure 4.8b) and 
without (Figure 4.8a) microplate washing (3 x 250 μL buffer) to remove unbound 
liposomes.  In both cases, the microplate was initially analyzed for fluorescence using a 
microplate reader with excitation using a 460 nm (± 40 nm) filter and emission detected 
with a 528 nm (± 20 nm) filter.  At this point, 30 μL of a 20% Triton X-100 solution was 
added to lyse the vesicles, which was followed by a repeat of the previous fluorescence 
measurement.  Subsequent addition of the detergent did not lead to a further increase 
in fluorescence, indicating that all liposomes had been lysed. 
 
Microplate analysis of whole liposome-PKC  binding: Microplate protein-binding 
experiments were performed using white streptavidin-coated 96-well microplates. The 
wash buffer that was used was 20 mM HEPES buffer pH 7.4 with 100 mM sodium 
chloride and 1mM calcium chloride for PKC activation. First, the wells that were to be 
used for analysis were washed with 200 μL of wash buffer for 30 minutes. This was 
removed, followed by introduction of different concentrations of liposomes (100 μL of 




Next, these solutions were removed and the wells were washed with 3 x 250 μL wash 
buffer. Following this, 200 μL of a 100 ng/mL solution of PKC  in wash buffer was 
added to each well, followed by a one-hour incubation.  At this point, the protein solution 
was removed and the wells were washed with 3 x 250 μL wash buffer.  Next, 200 μL of 
a 100 ng/mL solution of rabbit anti-PKC  antibody was added to each well and allowed 
to incubate for one hour. This solution was then removed and the wells were washed 
with 3 x 250 μL wash buffer. Finally, wells were incubated with goat anti-rabbit IgG 
HRP-conjugate for one hour and then washed with 3 x 250 μL wash buffer and 1 x 100 
μL water.  Chemiluminescence detection of bound antibody was next performed using 
supersignal ELISA femto maximum sensitivity substrate. Here, a 1:1 mixture of the 
substrate and peroxide solutions were mixed and 100 μL of the resulting solution was 
added to each well. The microplate was then immediately placed in the microplate 
reader and the luminescence at 425 nm was repeatedly measured for ~ 5 minutes.  
Assays were run numerous times, both simultaneously and on separate occasions 
using newly formed solutions. The chemiluminescence data was then plotted verses the 
original incubation concentrations using SigmaPlot to curve fit the data (non-linear 
regression using the Langmuir binding isotherm).   
 
Attempts at whole liposome-lectin binding assay: Microplate protein-binding 
experiments were performed using black streptavidin-coated 96-well microplates. The 
wash buffer that was used was 20 mM HEPES buffer pH 6.5 with 100 mM sodium 




otherwise stated) for lectin activation. First, the wells that were to be used for analysis 
were washed with 200 μL of wash buffer for 30 minutes. This was removed, followed by 
introduction of different concentrations of liposomes (100 μL of appropriate solutions in 
wash buffer) and then incubation for one hour.  Next, these solutions were removed and 
the wells were washed with 3 x 200 μL wash buffer. Following this, 200 μL of a 
appropriate μg/mL solution of lectin in wash buffer (with BSA as indicated) was added to 
each well, followed by a one-hour incubation.  At this point, the protein solution was 
removed and the wells were washed with 3 x 200 μL wash buffer. The microplate was 
then analyzed for fluorescence using a microplate reader with excitation using a 460 nm 
(± 40 nm) filter and emission detected with a 528 nm (± 20 nm) filter.   
 For experiments using low/hign Mn+2 concentrations (Figure 4.13), liposomes 
were prepared in buffer with Mn+2. These stock solutions were then diluted with 
an identical buffer solution minus the Mn+2 for the low samples. 
 For experiments using GNL, buffer consisted of 20 mM HEPES, 150 mM NaCl, 








































































































































































































































































































































































































































































































































Chapter 5: Click Chemistry Using Azido and Alkyne Based Lipids 
Presented in Liposomes: Towards a Chemical Approach for Vesicle 
Fusion 
 
Background and Significance 
Membrane fusion is a process that is frequently observed in cellular processes 
such as fertilization, endocytosis, exocytosis, and cell division. However, the fusion of 
membranes is not a spontaneous process and requires significant amounts of energy to 
occur. This energy is provided by specialized fusion proteins.128 In order to develop a 
system that mimics this process without requiring fusion proteins, an environment that 
closely resembles that of a cell is needed.163 Liposomes fufill this criteria as they exist in 
a bilayer structure and can be functionalized through the incorporation of various 
molecules to present specific ligands or molecules on the surface.  
To date, most artificial fusion systems employ molecular recognition techniques 
in order to promote the process. For example, accounts of induced vesicle fusion 
utilizing small molecule interactions capable of producing electrostatic interactions and 
multiple hydrogen bonds,163-168 such as those between vancomycin and peptides164, 165 
and between cyanuric acid and melamine,166 have been reported. Fusion is also known 
to be induced through metal ion binding by amphiphilic 2,2’-bipyridine ligands.169 A pH 
sensitive fusion system using coiled-coil polypeptides is also known.170 One of the main 
drawbacks of such systems lies in the fact that they utilize molecules and recognition 




such systems in vivo.  
Therefore, we sought to design a system that would allow specific interaction 
between the two liposomes that we targeted for fusion. We hypothesized that if an azide 
could be introduced at the surface of one liposome and an alkyne at the surface of 
another, then “click” chemistry could be used to covalently tether between the 
liposomes. This linkage would bring the liposomes into proximity in order to promote 
vesicle fusion. This approach is particularly appealing as both azide and alkynes are 
generally unreactive to cellular components, and at the same time, potentially non-toxic 
to the cell.  
 
Synthesis of Lipids for Vesicle Fusion 
In order to modify the surface of liposomes utilizing “click” chemistry, lipids 
capable of presenting azides and/or alkynes at the surface must be designed. 
Considerations in the design of such lipids include incorporation of a headgroup that will 
keep the lipid high enough in the membrane to present the azide/alkyne at the surface 
level of the membrane, incorporating a tether that will maintain enough distance 
between the azide/alkyne and the surface in order to give it ample space to react, and 
tethering it to the lipid in a manner that will prevent it from “dipping” back and becoming 
buried in the hydrophobic region of the bilayer. With these considerations in mind, we 
sought to utilize azido-lipid 4.2.2 (figure 5.1) as a scaffold for incorporating azide and 
alkynes onto the lipid. The azide of 4.2.2 can react with a corresponding alkyne via 






















exist within the bilayer, therefore maintaining presentation at the surface. The synthesis 
of an azide-presenting lipid 5.2.1a using this methodology is presented in figure 5.2. 
First, ester 4.3.4153 is converted into alkyne 5.2.2 via hydrolysis of the ethyl ester 
followed by coupling with propargyl amine. Next, cycloaddition with 4.2.2 furnished 
TEG-alcohol lipid 5.2.3, which was converted to the azide 5.2.1a through a mesylate 
intermediate. Synthesis of a TEG-alkyne lipid is presented in figure 5.3. Initially, alkyne 
4.3.8153 is coupled with 4.2.2 to afford Boc-protected lipid 5.3.4. Following Boc removal 
and coupling to acid 5.3.5, TEG-alkyne lipid 5.3.1b is obtained. 
In order to monitor activity and success of the “click” reactions to be carried out 
on the liposome surface, we chose to use a FRET based approach. It is known that 
carboxylates present in a fluorescent molecule can coordinate copper ions and quench 
fluorescence.171 Therefore, we sought to use fluorophores that do not coordinate to 
copper ions and decided to develop NBD-lipid 5.4.8a and rhodamine-lipid 5.4.8b, as 
these fluorophores have proven effective in monitoring the modification of liposome 
surfaces via “click” chemistry.158 The synthesis of lipids 5.4.8a and 5.4.8b is presented 
in figure 5.4. Each was accessed from coupling of the chloro analogue of each 
fluorophore with propargyl amine, followed by “click” reaction with azido-lipid 4.2.2. 
 
Surface Modification of Liposomes via “Click” Chemistry 
Having developed lipids capable of presenting “clickable” substrates on the 
surface of liposomes, we sought to verify that such modifications were occurring. 




































































































were incorporated into liposomes at 10%, 1%, and 89% respectively. Reasoning that 
rhodamine-alkyne 3.7.19d would be more water soluble than NBD-alkyne 5.4.7 due to 
its charge, we decided to attempt to “click” it onto TEG-azido lipid 5.2.1a. Liposomes 
were added to rhodamine-alkyne and CuBr and then allowed to react 20 h with 
occasional monitoring of the fluorescence (figure 5.5), the results of which are 
presented in figure 5.6. Both samples exhibited a small amount of rhodamine 
fluorescence due to weak excitement of the rhodamine by the light used to excite the 
NBD. As seen from the graph, the initial fluorescence observed for the NBD-lipid (520 
nm) was lower compared to that observed in the control sample without CuBr. We 
reasoned that the decrease of the NBD signal was not the result of FRET as the 
rhodamine signal was also initially lower than the control. Therefore, it seems that the 
NBD fluorescence is in some way being quenched by the copper ions. However, after 
20 h the intensity of the rhodamine fluorescence in the “click’ reaction had risen slightly 
above that observed for the control. This indicates that the rhodamine species is being 
excited more than initially observed. The possibility that energy from NBD emission is 
exciting the rhodamine and that FRET is being observed is indicated by two factors. 
First, the level of the rhodamine fluorescence does not increase in the control from the 
start to the end of the reaction. Also, in the “click” reaction, the rhodamine fluorescence 
has shifted, potentially indicating an alternative method for excitement. These results 
seem to indicate that indeed our system is viable for the surface modification of 








Figure 5.5. Representation of using FRET to monitor the surface modification of 








Figure 5.6. Fluorescence readings obtained during surface modification of 
liposomes composed of PC, 5.2.1a, 5.4.8a through reaction with alkyne 3.7.19d. 
The blue (initial reading) and red (final reading) lines represent control 
experiments in which no CuBr was added. The green (initial reading) and brown 





























Attempts at Vesicle Fusion via “Click” Chemistry  
In an attempt to develop a procedure for vesicle fusion promoted by an 
irreversible, bio-orthogonal chemical reaction, we once again turned our focus to design 
a system that utilizes “click” chemistry. A representation of such a system is shown in 
figure 5.7.  
Originally we planned on detecting the fusion with FRET. One liposome would be 
doped with a FRET donor lipid and the other with a FRET acceptor, which should 
effectively turn on FRET upon fusion. Initially, a carboxyfluorescein lipid was used as 
the FRET donor, but the fluorescence of the CBF was completely quenched and never 
regenerated during the course of the reaction. Therefore, NBD-lipid 5.4.8a and 
rhodamine-lipid 5.4.8b were used as the donor and acceptor respectively. As was 
observed in the surface modification experiments discussed above, the initial intensity 
of the NBD fluorescence was lower than that observed for the control (no CuBr). Also, 
the intensity for both the NBD and rhodamine fluorescence remained lower than the 
control during the entire course of the reaction. Due to the inability to tell how 
significantly the fluorescence was changing over the course of the reaction, an 
alternative method for the detection of fusion was sought.  
A common approach used to verify the fusion of two vesicles is a dye leakage 
assay. Therefore, 5(6)-carboxyfluorescein was encapsulated into vesicles composed of 
10% azide 5.2.1a and 90% PC. These were then reacted with vesicles composed of 
10% alkyne 5.3.1b and 90% PC in the presence of CuBr. However, no distinct 








Figure 5.7. Representation of vesicle fusion promoted through covalent 





















solutions with CuBr and those without. 
In a final attempt to determine if vesicle fusion promoted by “click” chemistry was 
occurring, the mean diameter of the vesicles was measured by dynamic light scattering  
over the course of the reaction. Results are shown in figure 5.8. As can be seen from 
the plot, control samples containing no CuBr show a relatively constant mean diameter 
over a 1 h reaction time. The average diameter observed for the “click” reaction solution 
with azide liposomes, alkyne liposomes, and CuBr changes over time and eventually 
levels off at a diameter roughly twice that initially observed. Two control experiments 
were carried out to test the selectivity of the “click” reaction. Solutions of vesicles 
comprised of 10% azide 5.2.1a and 90% PC and solutions with 10% alkyne 5.3.1b and 
90% PC were prepared and exposed to CuBr. As seen from the graph in figure 5.8, the 
size of the vesicles in each of these experiments increases in a manner similar to that 
observed for the actual “click” reaction set. These results, along with the absence of an 
increase in vesicle size for those without any CuBr, seem to indicate that the copper ion 
is responsible in some way for the change in size.  
It is known that metal ions that can complex to certain lipids exposed on the 
surface can induce reorganization within the bilayer.172 If the lipids are present at 
relatively high concentrations (0.1 mM), then this chelation and reorganization can 
facilitate the formation of bilayer stacks that possess a column shape.173 In this case, 
upon addition of the coordinating metal, the solution became turbid. In the three 
instances above that showed an increase in vesicle diameter, increased turbidity of the 
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cycloadditions by coordinating an azide and alkyne. This coordination brings them into 
proximity and forces the cycloaddition. Therefore, it seems reasonable that in the 
controls that contained liposomes with either the azide or alkyne, the Cu+ could 
potentially coordinate to two alkynes or two azides, thereby bringing the vesicles into 
proximity to each other and promoting fusion, or at least aggregation. This would 
explain both the increase in diameter and turbidity that was observed in all three cases. 
In attempts to verify whether the vesicles fuse or simply aggregrate in the presence of 
copper (I) ions, a copper-free version of this process is currently being developed in our 
lab. This approach should also lend itself compatible to monitoring the fusion event 




All reagents were purchased from Acros or Aldrich and used as received. Dry solvents 
were obtained from a Pure Solv solvent delivery system purchased from Innovative 
Technology, Inc. Column chromatography was performed using 230 - 400 mesh silica 
gel purchased from Sorbent Technologies. NMR spectra were obtained using a Bruker 
AC250 spectrometer updated with a TecMag data collection system, a Varian Mercury  
300 spectrometer or a Bruker Avance 400 spectrometer. Mass spectra were obtained 
with JEOL DART-AccuTOF and ABI Voyager DE Pro MALDI spectrometers. Optical 
rotation values were obtained using a Perkin-Elmer 241 polarimeter. L-α-




Liposome extruder and polycarbonate membranes were obtained from Avestin (Ottawa, 
Canada). Fluorescence measurements were carried out on a PerkinElmer LS 55 
Fluorescence Spectrometer. DLS measurements were carried out on a Brookhaven 
Instruments BI-200SM goniometer (633 nm) and a BI-9000AT digital correlator. 
Characterization of compounds 4.2.2, 4.3.4, and 4.3.8 are given in Chapter 4. Those for 
compound 3.7.19d are given in Chapter 3. 
 
Synthetic Procedures 
14-Hydroxy-N-(prop-2-ynyl)-3,6,9,12-tetraoxatetradecan-1-amide (5.2.2). Alcohol 
4.3.4 (2.32 g, 8.28 mmol) was dissolved in methanol (8 mL). With stirring 2 M NaOH 
was added and stirring was continued for 40 minutes. The solution was neutralized with 
Dowex® 50WX8-200 H+ ion exchange resin to pH 4. The resin was removed via filtration 
and the filtrate was concentrated under reduced pressure. The residue was suspended 
in toluene and concentrated once again. 
At this point, the residue was dissolved in dichloromethane (50 mL). With stirring 
propargyl amine (682 μL, 9.94 mmol), 1-ethyl-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (1.9 g, 9.94 mmol), 4-dimethylaminopyridine (1.01 g, 8.28 mmol), and N- 
methylmorpholine (2.74 mL, 24.84 mmol) were added. The solution was stirred at room 
temperature overnight. The reaction mixture was extracted with 2 M HCl and 
dichloromethane. The organic layer was dried with magnesium sulfate, filtered, and the 
solvent removed under reduced pressure. Column chromatography with silica gel and a 




1H NMR (300 MHz, CDCl3) δ 7.61 (s, 1H), 4.11–4.09 (m, 2H), 4.03 (s, 1H), 3.76–3.60 (m, 16H), 
3.05 (s, 1H), 2.26–2.24 (t, J = 2.9 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ170.0, 79.8, 72.5, 




yl)propane-1,2-diyl distearate (5.2.3). Alkyne-alcohol 5.2.2 (69 mg, 0.238 mmol) and 
(S)-3-azidopropane-1,2-diyl distearate 4.2.2 (155 mg, 0.238 mmol) were dissolved in 
THF (1.5 mL). Copper sulfate pentahydrate (173 mg, 3 mmol) and sodium ascorbate 
(275 mg, 6 mmol) were added, along with water (0.5 mL). The reaction was stirred at 
room temperature overnight and the solvent was then removed under reduced 
pressure. Column chromatography with silica gel and a solvent system of 10% 
methanol-chloroform afforded 5.2.3 as a white solid (131 mg, 59%). 
[α]D
296K + 1.22 (C = 5.25, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.97 (t, J = 5.6 Hz, 1H), 7.65 
(s, 1H), 5.39–5.36 (m, 1H), 4.64–4.54 (m, 4H), 4.32 (dd, J = 4.1, 12 Hz, 1H), 4.08–4.01 (m, 3H), 
3.73–-3.43 (m, 17H), 2.36–2.27 (m, 4H), 1.62–1.57 (m, 4H), 1.26 (b s, 56H), 0.88 (t, J = 6.3 Hz, 
6H); 13C NMR (75.5 MHz, CDCl3) δ 173.1, 172.6, 145.3, 123.6, 72.6, 70.9, 70.5, 70.4, 70.22, 
70.18, 69.3, 62.0, 61.5, 50.0, 34.2, 34.0, 31.9, 29.72, 29.67, 29.5, 29.4, 29.3, 29.1, 29.0, 24.8, 
24.7, 22.7, 14.1;  MALDI–HRMS [M + Na]+ calcd: 961.7175, found: 961.7190. 
 
(S)-3-(4-(16-Azido-3-oxo-5,8-11,14-tetraoxa-2-azahexadecyl)-1H-1,2,3-triazol-1-
yl)propane-1,2-diyl distearate (5.2.1a). Lipid alcohol 5.2.3 (129 mg, 0.137 mmol) was 




(57 μL, 0.411 mmol) and methanesulfonyl chloride (10.8 μL, 0.138 mmol) were added.  
Stirring was continued at 0 ºC for 1 h. The solvent was removed under reduced 
pressure and the residue was dissolved in DMF. Sodium azide (17.8 mg, 0.274 mmol) 
was added and the reaction was heated at 85 ºC overnight. The solvent was removed 
under reduced pressure and column chromatography with silica gel and a solvent 
system of 5% methanol-chloroform afforded 5.2.1a as a tan solid (103 mg, 78%). 
[α]D
296K – 0.17 (C = 4.12, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.72 (b s, 1H), 7.62 (s, 1H), 
5.39–5.35 (m, 1H), 4.62–4.50 (m, 4H), 4.31 (dd, J = 4.2, 12 Hz, 1H), 4.08–4.00 (m, 3H), 3.77–
3.61 (m, 14H), 3.39 (t, J = 4.8 Hz, 2H), 2.36–2.27 (m, 4H), 1.62–1.57 (m, 4H), 1.25 (b s, 56H), 
0.88 (t, J = 6.3 Hz, 6H); 13C NMR (75.5 MHz, CDCl3) δ 173.1, 172.5, 145.2, 123.4, 71.3, 71.1, 
70.7, 70.6, 70.4, 70.2, 70.0, 69.3, 62.0, 50.6, 50.0, 42.8, 34.2, 34.0, 31.9, 29.72, 29.68, 29.6, 




1H-1,2,3-triazol-1-yl)propane-1,2-diyl distearate (5.3.4).    Alkyne 4.3.8 (68 mg, 0.175 
mmol) and (S)-3-azidopropane-1,2-diyl distearate 4.2.2 (155 mg, 0.238 mmol) were 
dissolved in THF (1.5 mL). Copper sulfate pentahydrate (131 mg, 0.525 mmol) and 
sodium ascorbate (208 mg, 1.05 mmol) were added along with water (0.5 mL). The 
reaction was stirred at room temperature overnight and the solvent was removed under 
reduced pressure. Column chromatography with silica gel and a solvent system of 50% 





296K + 0.21 (C = 4.24, CHCl3); 
1H NMR (300 MHz, CDCl3 + CD3OD) δ 7.91 (b s, 1H), 
7.70 (b s, 1H), 5.40–5.36 (m, 2H), 4.61–4.55 (m, 4H), 4.33 (dd, J = 4.1, 12.2 Hz, 1H), 
4.09–4.01 (m, 3H), 3.66–3.52 (m, 14H), 3.31–3.29 (m, 2H), 2.37–2.28 (m, 4H), 1.64–
1.55 (m, 4H), 1.44 (s, 9H), 1.26 (b s, 56H), 0.88 (t, J = 6.6 Hz, 6H); 13C NMR (100.6 MHz, 
CDCl3 + CD3OD) δ 173.1, 172.5, 170.2, 156.0, 145.4, 123.6, 79.1, 71.1, 70.5, 70.3, 69.4, 69.3, 
62.0, 50.1, 40.3, 34.0, 31.93, 31.88, 29.7, 28.4, 24.8, 22.7, 14.1; MALDI–HRMS [M + Na]+ calcd: 
1060.7859, found: 1060.7831. 
 
4-Oxo-4-(prop-2-ynylamino)butanoic acid (5.3.5). Propargyl amine (200 μL, 2.92 
mmol) was dissolved in acetonitrile/DMF (2/1, 20 mL) under nitrogen at 0 ºC. Succinic 
anhydride (292 mg, 2.92 mmol) was dissolved in acetonitrile/DMF (2/1, 10mL) and 
added to the stirring solution. The solution was allowed to gradually warm to room 
temperature and stirring was continued overnight. The solvent was removed under 
reduced pressure and the solid  was washed with hexanes to afford 5.3.5 as a tan solid 
(447 mg, 99%). 
1H NMR (300 MHz, CD3OD) δ 3.94 (s, 2H), 2.61–2.45 (m, 5H); 
13C NMR (75.5 MHz, CD3OD) δ 
176.2, 164.1, 80.6, 72.2, 31.2, 30.1, 29.5, ; HRMS [M + H]+ calcd: 156.06607, found: 156.06495. 
 
(S)-3-(4-(3,18,21-Trioxo-5,8,11,14-tetraoxa-2,17-22-triazapentacos-24-ynyl)-1H-
1,2,3-triazol-1-yl)propane-1,2-diyl distearate (5.3.1b). Boc-TEG-Lipid 5.3.4 (106 mg, 
0.102 mmol) was dissolved in dichloromethane (2 mL) and with stirring trifluoroacetic 




the solvent was removed under reduced pressure. 
At this point, the residue was dissolved in DMF (1 mL). With stirring N-methylmorpholine 
(112 μL, 1.02 mmol) was added. 1-ethyl-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (23 mg, 0.123 mmol), 4-dimethylaminopyridine (12.5 mg, 0.102 mmol), 
and succinic acid-alkyne 5.3.5 (19 mg, 0.123 mmol) were combined in DMF (2 mL). 
This solution was added with stirring to the solution prepared aboved. The combination 
of solutions was stirred at room temperature overnight. The solvent removed under 
reduced pressure. Column chromatography with silica gel and a solvent system of 10% 
methanol-chloroform afforded 5.3.1b as a white solid (72 mg, 65%). 
[α]D
296K + 0.11 (C = 3.59, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.88 (b s, 1H), 7.67 (b s, 1H), 
7.06 (b s, 2H), 5.30–5.37 (m, 1H), 4.65–4.52 (m, 4H), 4.33 (dd, J = 4.2, 12 Hz), 4.09–4.00 (m, 
5H), 3.66–4.43 (m, 16H), 2.55 (s, 4H), 2.36–2.27 (m, 4H), 2.23 (t, J = 2.4 Hz, 1H), 1.64–1.57 
(m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 6.6 Hz, 6H); 13C NMR (75.5 MHz, CDCl3) δ 173.2, 172.6, 
172.1, 170.4, 169.4, 145.5, 123.7, 79.9, 71.2, 71.0, 70.54, 70.50, 70.4, 70.2, 69.8, 69.4, 62.0, 
50.1, 39.3, 34.3, 34.0, 31.9, 31.6, 31.4, 29.71, 29.67, 29.5, 29.4, 29.3, 29.1, 29.0, 24.8, 24.7, 
22.7, 14.1; MALDI–HRMS [M + Na]+ calcd: 1097.7812, found: 1097.7857. 
 
4-Nitro-7-N-(prop-2-ynyl)benzofurazan (5.4.7). 4-Chloro-7-nitrobenzofurazan 5.4.6 
(100 mg, 0.501 mmol) was dissolved in THF. Diisopropylethylamine (248 μL, 1.50 
mmol) and propargyl amine (41 μL, 0.601 mmol) were added and the solution was 
stirred at room temperature overnight. The solvent was removed under reduced 




50-100% ethyl acetate-hexanes afforded 5.4.7 as an orange solid (92.4 mg, 85%). 
1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 8.7 Hz, 1H), 6.41 (b s, 1H), 6.37 (d, J = 8.4 Hz, 1H), 
4.34–4.31 (m, 2H), 2.45–2.43 (m, 1H); No 13C NMR could be obtained; HRMS [M + H]+ calcd: 
219.05181, found: 219.05224. 
 
NBD-lipid (5.4.8a). NBD-alkyne 5.4.7 (17.5 mg, 0.080 mmol) and (S)-3-azidopropane-
1,2-diyl distearate 4.2.2 (57.4 mg, 0.088 mmol) were dissolved in THF (1.5 mL). Copper 
sulfate pentahydrate (60 mg, 0.240 mmol) and sodium ascorbate (95 mg, 0.480 mmol) 
were added along with water (0.5 mL). The reaction was stirred at room temperature 
overnight and the solvent was removed under reduced pressure. Column 
chromatography with silica gel and a gradient solvent system of 50-100% ethyl acetate-
hexanes afforded 5.4.8a as an orange solid (30.2 mg, 43%). 
1H NMR (300 MHz, CD2Cl2) δ 8.48 (d, J = 9 Hz, 1H), 7.72 (s, 1H), 7.26 (b s, 1H), 6.38 (d, J = 
8.4 Hz, 1H), 5.40–5.37 (m, 1H), 4.81 (s, 2H), 4.62–4.61 (m, 2H), 4.28 (dd, J = 4.1, 12.2 Hz, 1H), 
4.06 (dd, J = 5.4, 12 Hz, 1H), 2.33–2.21 (m, 4H), 1.60–1.47 (m, 4H), 1.25 (b s, 56H), 0.88 (t, J = 
6.5 Hz, 6H); No 13C NMR could be obtained; MALDI–HRMS [M + Na]+ calcd: 890.6090, found: 
890.6039. 
 
Rhodamine Lipid (5.4.8b).  Azido-lipid 4.2.2 (18.5 mg, 0.029 mmol) and rhodamine 
alkyne 3.7.19d (17 mg, 0.029 mmol) were dissolved in THF (0.5 mL). Copper sulfate 
pentahydrate (21 mg, 0.086 mmol) and sodium ascorbate (34 mg, 0.171 mmol) were 




overnight and the solvent was removed under reduced pressure. Column 
chromatography with silica gel and a gradient solvent system of 2-5% methanol-DCM 
afforded 5.4.8b as a purple solid (27.5 mg, 77%). 
1H NMR (300 MHz, CDCl3+ CD3OD) δ 8.36 (b s, 1H), 8.01 (d, J = 8.1 Hz, 1H), 7.83 (s, 1H), 
7.23–7.13 (m, 3H), 6.96–6.88 (m, 2H), 6.75–6.74 (m, 2H), 5.41 (b s, 1H), 4.73–4.55 (m, 2H), 
4.42 (s, 2H), 4.34 (dd, J = 3.9, 12 Hz, 1H), 4.00 (dd, J = 6.6, 12 Hz, 11.7 Hz, 1H), 3.70–3.61 (m, 
8H), 2.33–2.23 (m, 4H), 1.56 (b s, 4H), 1.26 (b s, 56H), 0.88 (t, J = 6.3 Hz, 6H); 13C NMR (100.6 
MHz, CDCl3 + CD3OD) δ 173.5, 172.9, 158.04, 157.99, 142.6, 133.5, 133.4, 133.3, 130.1, 
127.8, 126.9, 124.6, 114.3, 113.8, 113.7, 95.8, 69.4, 62.3, 45.9, 38.5, 34.1, 34.0, 32.0, 29.8, 
29.6, 29.44, 29.38, 29.2, 29.1, 24.9, 24.8, 22.8, 14.1, 12.6; MALDI–HRMS [M + Na]+ calcd: 
1267.7461, found: 1267.7517. 
 
 
Details for Experiments Involving Liposomes 
General procedure for liposomes preparation. Solid lipids were dissolved in 
chloroform to a particular concentration and a specific amount of each lipid in solution 
was added to a small glass container. The chloroform was removed under a constant 
stream of nitrogen and the resulting lipid film was dried under vacuum. The 
appropriate volume of buffer was added to the dried lipids in order to produce a specific 
concentration of liposomes after hydration and size reduction. The suspension of lipid 
and buffer was agitated at 40 °C for 40 min and then subjected to 10 freeze-thaw 




membrane to control liposome size. 
 
General procedure for surface modification via “click’ chemistry. Liposomes 
consisting of 10% TEG-azido lipid 5.2.1a, 1% NBD-lipid 5.4.8a, and 89% PC were 
prepared in buffer consisting of 10 mM HEPES, 145 mM NaCl, pH 6.5. Rhodamine 
alkyne 3.7.19d was added to the reaction vessel in a chloroform solution to that would 
provide a final concentration of 200 μM (2 eq of azide concentration). Following 
evaporation of the chloroform and drying of the residue, liposomes (1 mM final 
concentration) and CuBr (2.2 mM final concentration) were added to the alkyne and 
diluted to a final volume of 1 mL with buffer. Fluorescence measurements (100 μL 
volumes) were measured at various time intervals during the 20 h reaction time. 
 
General procedure for monitoring vesicle size with DLS. Liposomes consisting of 
10% of TEG-azido lipid 5.2.1a or 10% of TEG-alkyne lipid 5.3.1b and 90% PC were 
prepared in buffer consisting of 10 mM HEPES, 145 mM NaCl, pH 6.5. Samples were 
prepared to provide a total liposome concentration of 1 mM. For the click reaction 
samples were prepared consisting of 500 μM of liposomes with 5.2.1a, 500 μM of 
liposomes with 5.3.1b, and 2.2 mM CuBr in a final volume of 1 mL. Control samples 
were prepared at the same concentration of liposomes with the exclusion of the CuBr. 
For experiments using only azide or alkyne doped liposomes, the solutions were 
prepared in 1 mL buffer with 1 mM appropriate liposome solution and 2.2 mM CuBr. In 




size measurements. The change in size of the vesicles was measured over an 
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